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Atomic force nanoscopy and spectroscopy applied to nanomedicine 
Salvatore Cannistraro   
Biophysics & Nanoscience Centre, Dipartimento DEB, Università della Tuscia, Viterbo, Italy  
Email of presenting author: cannistr@unitus.it. 
Atomic Force Microscopy (AFM)  is a rewarding  nanotechnological tool which has boosted research 
in the field of nanomedicine. It is able to measure interaction forces in biomolecular systems in the 
order of picoNewton, without labelling, in physiological media, at the level of single molecular 
structures, and even when molecules and cells are at work. It is therefore possible: i) to image 
structures at the nanoscale; ii) to measure single ligand-receptor couple interaction strength; iii) to 
determine the viscosity/elasticity of cells or of their substructure; iv) to capture the molecular or 
cellular motions; v) to study the unfolding of biomolecules; and so on. The most important 
applications of AFM  of particular relevance to nanomedicine will be reviewed.     
  
See refs at the website: www.unitus.it/biophysics  
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Advanced Fluorescence Microscopy to Study Nanomedicines 
Stefaan C. De Smedt, Kevin Braeckmans, Katrien Remaut, Koen Raemdonck, Jo Demeester  
Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, Ottergemsesteenweg 
460, B-9000 Ghent, Belgium, 0032-9-2648098, Ghent Research Group on Nanomedicines Ghent 
University, B-9000 Gent, Centre for Nano- and Biophotonics, Ghent University, B-9000 Gent, 
Belgium 
Email of presenting author: Stefaan.DeSmedt@UGent.be 
In the drug delivery field, interest goes to developing ‘intelligent’ nanoscopic particles that are capable 
of efficiently delivering biopharmaceuticals to target cells. These nanoparticle formulations should 
fulfill several requirements. Besides efficiently encapsulating the biopharmaceuticals, they also have 
to provide protection against degradation during the entire delivery process. Furthermore, the 
nanoparticles should not aggregate e.g. after intravenous injection. Nor should they release the 
therapeutic cargo while being suspended in the blood circulation or when traversing the extracellular 
space. Release of the biopharmaceuticals in many cases should only occur after being internalized in 
the target cells. Obtaining a better insight into the physicochemical and biophysical behaviour of the 
nanoparticles during the various phases of the delivery process is required to achieve efficient 
optimization of their structure and composition.  
For more than 10 years, our group has been exploring the use of advanced fluorescence microscopy 
methods for this purpose. Detailed information on the mobility and potential binding of nanoparticles 
in extracellular tissues can be obtained using fluorescence recovery after photobleaching (FRAP) or 
fluorescence Single Particle Tracking (fSPT). These techniques were for instance used to examine the 
mobility of nanoparticles in lung sputum of cystic fibrosis patients and vitreous humour. We have used 
fluorescence correlation spectroscopy (FCS) to study the association and dissociation of nucleic acids 
from nanomedicine formulations in biological media, such as sera, cell lysates and cells. 
Complementary to that, fSPT has proven to be a unique tool to accurately measure nanoparticle 
aggregation and concentration in biological fluids. Finally, using fSPT and live cell microscopy we 
succeeded in unraveling the intracellular trafficking of nanoparticles in great detail.  
By providing a better insight into the stability and transport of nanoparticles during the various phases 
of the delivery process through the use of advanced microscopy techniques, it is our aim to enable a 
more efficient and rational development of improved carrier materials for the delivery of nucleic acids.  
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Novel strategies to actively target gold nanoparticles to malignant cells 
for cancer diagnostics and treatment 
Roberto Pinia, Fulvio Rattoa, Francesca Tatinia, Sonia Centib, Ida Landinic, Stefania Nobilic, Ewa 
Witortb, Franco Fusib, Sergio Capacciolib,  Enrico Minic 
a Institute of Applied Physics, National Research Council of Italy, Via Madonna del Piano 10, I-50019, 
Sesto Fiorentino, Italy; b Department of Experimental Biomedical and Clinical Science, University of 
Florence, Viale Pieraccini 6, I-50139 Firenze, Italy; c Department of Health Science, University of 
Florence, Viale Pieraccini 6, I-50139 Firenze, Italy. 
Email of presenting author: r.pini@ifac.cnr.it 
The combination of pulsed and CW near-infrared laser light with plasmonic particles such as gold 
nanorods is gaining relevance for the photoacoustic imaging and photothermal ablation of cancer. 
Selective targeting of malignant cells with these contrast agents may rely on complementary 
biochemical and biological strategies, including the use of specific probes or the exploitation of 
cellular vehicles. 
Here we move from a platform of PEGylated gold nanorods with plasmonic bands around 800 nm, 
good biological profiles, stability and efficiency of photoacoustic and photothermal conversion as well 
as potential to passively accumulate into solid tumors by their enhanced permeability and retention. In 
order to enhance this potential, we implemented different approaches for active delivery by 
functionalization with (i) antibodies against cancer antigen 125 (CA125), which is a common 
biomarker for ovarian lesions; (ii) inhibitors of carbonic anhydrases 9 and 12 (CAIX and CAXII), 
which are expressed by hypoxic cells such as those found in solid tumors; and (iii) by introducing 
macrophages as a versatile model of cellular vehicles that would phagocytose the particles and home 
to inflammatory lesions. 
We challenge these alternatives in vitro under relevant conditions and discuss issues and perspectives 
behind their optimization and synergy. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Cellular uptake of PEGylated gold nanorods by endocytosis in 
macrophages to be used as cellular vehicles.  
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Hybrid and breakable porous materials. Application in biomedicine  
Luisa De Cola, Eko A Prasetyanto, Laura Maggini, Alessandro Bertucci, Federica Fiorini, Dedy 
Septiady  
aDepartment Institute de Science et d'Ingénierie Supramoléculaires (ISIS), Université de Strasbourg, 8 
Rue G. Monge, 67000 Strasbourg, France and INT-KIT, Karlsruhe, Germany  
Email of presenting author: decola@unistra.fr 
The talk will focus on the synthesis, characterization and applications of porous organosilicates, 
silicates, to be used for in vitro and in vivo imaging. The use of ordered mesoporous silica will be 
illustrated as containers for molecules and for delivering PNA [1] and DNA [2] inside HeLa cells. The 
fate of the silica particles will be discussed and in particular their accumulation in specific location in 
the cells will introduce our newest finding of porous systems able to disintegrate upon an external 
stimulus [3]. Their delivery properties and their destruction kinetics will be shown with some 
examples. On the other hand such porous systems can be used as components for special type of 
hydrogels. This hybrid soft/hard material has very exciting properties such as a very high swelling, a 
high water content (>95%) and excellent mechanical stability. The hybrid scaffold has been used as 
matrix for 3D growth of cells. The pores of the particles can be indeed employed as food reservoir and 
we have demonstrated that cells in such conditions can live several days [4].  
 
Figure. A schematic representation 
of a nano- container with dye 
molecules inside the pores and 
oligonucleotides on the surface. The 
kinetics of the release of the 
different components have been 
studied 
 
1. R. Corradini, L. De Cola et al Adv. Healthcare Mater. 2014, online.  
2. L. De Cola et al. Chem. Eur. J. 2014 in press (cover of the issue).  
3. L. Maggini, E.A. Prasetyanto, L. De Cola et al. to be submitted  
4. F. Fiorini, L. De Cola et al. to be submitted  
Acknowledgments: We kindly thank the ERC advanced grant award (number 2009-247365) 
for financial support.  
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Bio-inspired nanocarriers for siRNA delivery  
Smadar Cohen 
The Center for Regenerative Medicine and Stem Cell (RMSC) Research, The Ilse Katz Institute for 
Nanoscale Science and Technology, and The Avram & Stella Goldstein-Goren Department of 
Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel 
Email of presenting author: scohen@bgu.ac.il 
Sub-cellular targeting of siRNA can drastically improve its efficacy while minimizing side effects. 
Here, I will describe the development of anionic polyplexes formed between siRNA and hyaluronan-
sulfate and mediated by calcium ion bridges. In addition to their potential biocompatibility compared 
to cationic carriers, the anionic siRNA polyplexes present several advantages; the simple preparation 
method under aqueous conditions ("green technology") enables mass production; and the use of 
hyaluronan-sulfate can enhance their targeting and uptake by certain cells carrying the HA receptor.  
Using this platform for delivering anti-EGFP siRNA, 85% silencing of EGFP was observed in EGFP-
transfected CT26 mouse cell cultures. EGFP knockdown corresponded with the substantial cell uptake 
of these polyplexes and their accumulation and targeting to the cell cytoplasm.  Similar levels of gene 
silencing of a more relevant therapeutic target (STAT3 transcription factor) were demonstrated in two 
human cancer cell lines: multiple myeloma (U266) and hepatocellular carcinoma (HepG2) as well as 
in primary cell cultures.  
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Fluorescent nanoplatforms for multimodal phototherapy 
Salvatore Sortino 
Laboratory of Photochemistry, Department of Drug Sciences, University of Catania, Viale A. Doria 
95125, Catania, Italy; Email: 
Email of presenting author: ssortino@unict.it 
The achievement of molecular nanoconstructs able to release multiple therapeutic species in a 
controlled fashion is a major challenge in the burgeoning field of nanomedicine.1 Light is a powerful 
tool for the introduction of bio-active agents in a cellular environment, mimicking an “optical syringe” 
with an exquisite control of three main factors, site, timing and dosage, which are determining for the 
therapeutic outcome.2 Moreover light-triggering is biofriendly and offers the additional advantages of 
not affecting important physiological parameters such as temperature, pH and ionic strength. In this 
context, the use of photoactive compounds having intrinsic fluorescence properties or their integration 
with suitable fluorogenic units is a fundamental requisite for an imaging-guided phototherapy. This 
allows indeed the visualization of the phototherapeutic agent in cells through fluorescence techniques 
and can provide a highly localized “burst” precisely at the desired sites.  Singlet oxygen (1O2) and 
nitric oxide radical (NO) are able to attack biological substrates of different nature (i.e., lipids, 
proteins, and DNA) representing multitarget therapeutic agents and avoiding Multiple Drug Resistance 
problems encountered with several conventional drugs often target-specific. Due to their short half-life 
and lack of charge, both 1O2 and NO radical diffuse in the cellular environment over short distances 
without inflicting systemic side effects 
common to general anticancer drugs. 
Finally, since NO release is 
independent from O2 availability, it very 
well complements the 
photodynamic therapy based on 1O2 at the 
onset of hypoxic conditions. For all these 
reasons, the combination of 1O2 with 
NO has received growing attention in the 
last few years3 with the exciting 
prospect to tackle cancer and 
bacterial diseases. 
In our laboratories, we have been 
working on the design and 
fabrication of a number of 
nanoplatforms merging multiple 
imaging and therapeutic photofunctionalities. This contribution illustrates some of the most recent and 
representative examples including molecular and supramolecular conjugates, polymer nanoparticles, 
hydrogels and quantum dots, highlighting the rationale design and their potential relevance in 
biomedical research. 
 
 
 
1. N. L. Komarova, C. R. Boland, Nature 2013, 499, 291. 
2. S. Sortino, J. Mater. Chem., 2012, 22, 301. 
3. S. Sortino, Chem. Soc. Rev. 2010, 39, 2903. 
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Magnetic hyperthermia and cell death: the impact of physiological 
media on the heating efficiency and cell uptake. 
Gerardo F. Goya,a,b M. Pilar Calatayud,a,b Laura Asin,a Beatriz Sanz,a,b Teobaldo E. Torres,a,b M. 
Ricardo Ibarra.a,b 
a Instituto de Nanociencia de Aragón, University of Zaragoza, M. Esquillor S/N, 50018, Zaragoza, 
Spain; b Departmento de la Materia Condensada, Facultad de Ciencias, Universidad de Zaragoza, 
Spain.  
Email of presenting author:  goya@unizar.es 
A central problem in nanomedicine is to understand the interaction of living organisms with man-
made nanometric objects like magnetic nanoparticles (MNPs), nanowires or nanotubes, because these 
objects can interact with cellular structures and substructures in unprecedented ways. MNPs can 
disrupt or promote molecular exchange across cell membrane as well as to produce specific effects on 
the metabolic cell pathways, setting the basis for new biomedical therapies such as the intracellular 
heating known as Magnetic Hyperthermia (MH). This technique relies on the use of MNPs as heat 
generators to induce localized cell death by the application of external alternating magnetic fields 
(AMF). The interaction between the magnetic moment of the MNPs and the applied AMFs dissipates 
energy that can be used to provoke the death of any target cell.  
 
Figure 1.  Evolution of the protein corona from the water-colloid state of MNPs 
to the protein-rich culture medium. 
 
The main aspects about the heating efficiency of MNPs in colloids have been successfully explained 
by simple physical models. [1] However, for in vitro and in vivo applications the proteins in the 
physiological medium yield the formation of a ‘protein corona’ that influences not only the 
physicochemical properties of the particles but also the internalization into a given cell type. [2] We 
show here how the process of protein adsorption onto different MNPs affects the cellular uptake 
pathways, and its consequences for the efficiency of the MFH experiments. Additionally, novel 
approaches for observing new MNP-cell interactions at the single-cell level through physical 
measurements will be presented. The potential benefits and limitations of the ‘Trojan horse’ strategy 
for immune-related therapies using human-monocyte-derived dendritic cells (DCs), and the 
universality of the induced cell death mechanisms will be discussed. 
 
1.Usov, N.A. and B.Y. Liubimov, Dynamics of magnetic nanoparticle in a viscous liquid: Application 
to magnetic nanoparticle hyperthermia. Journal of Applied Physics, 2012. 112(2). 
2.Calatayud, M.P., et al., The effect of surface charge of functionalized Fe3O4 nanoparticles on 
protein adsorption and cell uptake. Biomaterials, 2014. 35(24): p. 6389-6399. 
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Thermoresponsive liposomal nanomedicine and hyperthermia for the 
treatment of tumors 
Gerben A. Koning  
Innovative Targeting Group, Laboratory Experimental Surgical Oncology, Erasmus MC Cancer 
Institute, Rotterdam, The Netherlands. 
Email of presenting author: g.koning@erasmusmc.nl 
Liposomes have been successful as a nanomedicine for the delivery of chemotherapeutic drugs and are 
currently applied clinically in the treatment of various types of cancer. Efficacy of liposomal drug 
delivery is however hindered by limited levels of nanoparticle accumulation in tumors and by slow 
and uncontrolled drug release. Mild hyperthermia (HT), the heating of tumors to temperatures of 40-
43°C, has been developed as a clinical treatment modality in combination with chemo- and 
radiotherapy. The aim of our work is to use HT in combination with novel liposome design to further 
improve solid tumor chemotherapy.  
First, we studied whether HT can increase vascular permeability leading to increased intratumoral 
liposome deposition. Second, HT was used to trigger drug release interstitially from extravasated 
thermosensitive liposomes (TSL) [1]. Third, novel targeted TSL were designed to promote tumor 
targeting and cellular nanoparticle uptake in combination with triggered drug release [2]. Lastly, a 
novel intravascular drug delivery approach was applied, triggering drug release from TSL in tumor 
microcirculation [1].  
Intravital microscopy and whole body optical imaging proved that TSL extravasation and interstitial 
penetration can be strongly promoted upon HT in different tumor models [4]. Besides depending on 
passive tumor accumulation we designed cationic TSL that targeted tumor vasculature and tumor cells, 
where they were triggered for content release [2,5], causing significant tumor vascular damage. 
Triggered drug delivery following an intravascular [1,3,6] or interstitial drug release approach [1,7] 
imaged by intravital microscopy demonstrated delivery of doxorubicin (Dox) to tumor and tumor 
endothelial cells. Treatment of BLM melanoma by intravascular Dox release from fast-releasing TSL 
outperformed a treatment with interstitial Dox release from slow-releasing TSL [7]. These novel fast-
releasing TSL for intravascular Dox release proved more efficacious than lysolipid-Dox-TSL [4,6].  
The combination of hyperthermia with thermosensitive liposomes provides a promising approach to 
further improve chemotherapy for solid tumors.  
 
 
1. G.A. Koning, A.M. Eggermont, L.H. Lindner, T.L. ten Hagen, Pharm Res, 2010, 27, 1750. 
2. B.M. Dicheva, G.A. Koning, Expert Opin Drug Deliv, 2014, 11, 83. 
3. A.A. Manzoor, L.H. Lindner, C.D. Landon, J.Y. Park, A.J. Simnick, M.R. Dreher, S. Das, G. 
Hanna, W. Park, A. Chilkoti, G.A. Koning, T.L. ten Hagen, D. Needham, M.W. Dewhirst, Cancer 
Res, 2012, 72, 5566. 
4. L. Li, T.L. ten Hagen, M. Bolkestein, A. Gasselhuber, J. Yatvin, G.C. van Rhoon, A.M. Eggermont, 
D. Haemmerich, G.A. Koning, J Controlled Release, 2013, 167, 130. 
5. B.M. Dicheva, T.L Hagen, L. Li, D. Schipper, A.L. Seynhaeve, G.C. van Rhoon, A.M. Eggermont, 
L.H. Lindner, G.A. Koning, Nano Lett, 2013, 13, 2324. 
6. L. Li, T.L. ten Hagen, M. Hossann, R. Süss, G.C. van Rhoon, A.M. Eggermont, D. Haemmerich, 
G.A. Koning, J Controlled Release, 2013, 168, 142. 
7. L. Li, T.L. ten Hagen, A. Haeri, T. Soullié, C. Scholten, A.L. Seynhaeve, A.M Eggermont, G.A. 
Koning, J Controlled Release, 2014, 174, 202. 
 
 
Acknowledgments: Presented work was funded by various grants from SEHK, St. Fondsen, DKF, 
NanoNextNL, and EU COST Action TD1004 Theranostics Imaging and Therapy. 
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Smart Implants Equipped with Active Nanoreservoirs for 
Regenerative Nanomedicine 
N. Benkirane-Jessel 
INSERM “French National Institute of Health and Medical Research”; UMR1109; Université de 
Strasbourg. "Osteoarticular and Dental Regenerative Nanomedicine" Laboratory, Strasbourg, France 
Email of presenting author: Nadia.jessel@inserm.fr; http://www.regmed.fr 
Recently, we have reported a "Smart Hybrid Materials Equipped by Nanoreservoirs of Therapeutics 
and stem cells ". This unique nanotechnology strategy is used to entrap, protect, and stabilize 
therapeutic agents into polymer coatings acting as nanoreservoirs enrobing nanofibers of implantable 
membranes. Upon contact with cells, therapeutic agents become available through enzymatic 
degradation of the nanoreservoirs. As cells grow, divide, and infiltrate deeper into the porous 
membrane, they trigger slow and progressive release of therapeutic agents that, in turn, stimulate 
further cell proliferation. This constitutes the first instance of a smart living nanostructured hybrid 
membrane for regenerative medicine. The cell contact-dependent bioerodable nanoreservoirs 
described here will permit sustained release of drugs, genes, growth factors, etc., opening a general 
route to the design of sophisticated cell-therapy implants capable of robust and durable regeneration of 
a broad variety of tissues.  
 
ARTiOS NanoMedicine Start-up Project 
 
1.F. Fioretti, C. Mendoza-Palomares, M. Helms, D.A. Alam, L. Richert, Y. Arntz, S. Rinckenbach, F. 
Garnier, Y. Hakel, S.C. Gangloff, N. Benkirane-Jessel, ACS Nano. 2010, 22, 3277. 
2.S. Facca, C. Cortez, C. Mendoza-Palomares, N. Messadeq, A. Dierich, A.P.R. Johnston, D. Mainard, 
J.C. Voegel, F. Caruso, N. Benkirane-Jessel, Proc. Natl. Acad. Sci. USA. 2010, 107, 3406. 
3.C. Mendoza, A. Ferrand, S. Facca, F. Fioretti, D. Mainard, N. Benkirane-Jessel, ACS Nano. 2012, 6, 
483. 
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Enzyme sensitive nanomedicines for delivery of platinum based 
therapeutics  
Thomas L. Andresen, Anders E. Hansen, Fredrik Melander, Rasmus Eliasen, Rasmus Jølck, Jonas 
Henriksen, Rikke Brogaard 
aDepartment of Micro- and Nanotechnology, Technical University of Denmark, Building 423, 2800, 
Lyngby, Denmark;  
Email of presenting author: tlan@nanotech.dtu.dk 
One of the main design challenges in liposome based chemotheraputics has been the productive 
delivery of drugs that are not able to escape the liposomes easily, where cisplatinum has been a 
hallmark of this challenge (1). We have been focused on finding methods for utilizing enzymes to 
enhance the drug release rate of platinum based drugs in tumor tissue, where we have had particular 
success with targeting peptidases.  Drug release is achieved by surface coating the liposomes with 
molecules that are sensitive to enzymatic degradation. We have carried out biodistribution and PK 
studies, as well as tumor growth studies in mouse xenograft models with encouraging results. We 
furthermore utilized positron emission tomography (PET) for evaluating the developed drug delivery 
systems in vivo, which allowed us to study time resolved biodistribution of the drug delivery vehicles. 
PET imaging can furthermore be used to investigate therapeutic efficacy. We are currently 
investigating other platinum drugs using the developed formulation to compare differences in the 
therapeutic efficicacy. We also compared the peptidase activated drug delivery systems with PLA2 
activated systems, which showed that the former was superior in all tested tumor models. 
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Figure 1. Tumor growth curve of an oxaliplatinum liposome 
formulation (SPL1) in comparison to free oxaliplatinum and 
controls. 
 
 
 
1. Andresen TL, Jensen SS, Jørgensen, K. Advanced strategies in liposomal cancer therapy: Problems 
and prospects of active and tumor specific drug release. Prog. Lipid Res. 2005, 44(1), 68-97. 
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Poly(ethyl cyanoacrylate) nanoparticles for brain delivery of 
andrographolide 
Clizia Guccione,a  Cristina Grossi,b  Fiorella Casamenti,b  Benedetta Isacchi,a  Vieri Piazzini,a  
Maria Camilla Bergonzi,a  Anna Rita Bilia a 
a Department of Chemistry, University of Florence, via Ugo Schiff 6, 50019, Sesto Fiorentino, 
Florence, Italy; 
bDepartment of Neuroscience, Pharmacology and Child’s Health (NEUROFARBA), University of 
Florence, Viale Pieraccini 6, 50139, Florence, Italy 
Email of presenting author: clizia.guccione@unifi.it 
The limitations imposed by the blood-brain barrier (BBB) and the non-selective distribution of drugs 
in the brain have hindered the effective treatment of brain diseases and may result in severe side 
effects on the normal brains. Aim of this work was to deliver natural molecules into nanoparticles 
capable to provide sustained and controlled drug release, improved biodistribution and therapeutic 
efficacy for Alzheimer’s Disease (AD) prevention and therapy. Novel fluorescent polymeric 
nanoparticles to target brain tissues were designed and optimised to follow their in vivo distribution as 
new strategies to cross the BBB, namely ethylcyanoacrylate nanospheres (ECA-NSs) coated with 
polysorbate 80. They were prepared by emulsion polymerization method using fluorescein 
isothiocyanate linked to dextran as a florescent probe [1].  NSs were characterized in terms of 
dimension, polydispersity, zeta potential, morphology, encapsulation efficacy, loading capacity and 
stability of probe by DLS, TEM and HPLC-DAD-FLD, respectively. A study after intracerebral 
injection of nanoparticles in nucleus basalis magnocellularis of rats, colynergic neuronal location, 
evidenced that NSs did not induce inflammatory response. 
NSs were also administered intraperitoneally and intravenously to anaesthetized rats to evaluate their 
biodistribution by fluorescent microscope images. The biodistribution studies revealed that NSs were 
able to cross the BBB and reach brain tissue, as a consequence they were loaded with andrographolide, 
a major diterpenoid of Andrographis paniculata (Burm. f.) Nees, whose clinical utility for the 
treatment of inflammation-related neurodegenerative disorder has been demonstrated [2]. ECA-NSs 
were produced with good yields, suitable for the intraperitoneally administration (mean diameter ≤300 
nm; PDI 0.2), with a sphere-like shape and a good encapsulation efficacy.  
The developed nanocarriers represent a valuable targeting system for AD therapy. 
 
1. J. Kreuter, et al. Brain Research, 1995, 674, 171 
2. T. Wang, et al. The Journal of Pharmacology and Experimental Therapeutics, 2004, 308, 975 
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With the aim to design addressable magnetically-active carbon nanotubes (CNTs) for cancer 
treatment, the use of Fe-filled CNTs (Fe@MWCNTs) as multifunctional scaffolds is reported for 
exohedrally anchoring a monoclonal antibody (mAb, Fig. 1) known to bind a plasma membrane 
receptor over-expressed in several cancer cells (EGFR).[1] Comprehensive microscopic (TEM, AFM, 
and SEM) and spectroscopic (Raman, 57Fe Mӧssbauer, energy dispersive spectroscopy, XPS, X-ray 
diffraction) characterizations reveal the efficient confinement of magnetically-active Fe phases (α-Fe 
and Fe3C), while compositional evaluations through XPS, thermogravimetric analysis and gel 
electrophoresis confirm that mAb immobilization onto Fe@MWCNTs occurs. Enzyme-linked 
immunosorbent assay (ELISA), confocal microscopy imaging and western blotting confirm the 
targeting action toward EGFR-overexpressing cell lines (EGFR+). In vitro magnetic filtration 
experiments demonstrate that a selective removal of EGFR+ cells from a mixed population of healthy 
cell lines could be obtained in very short times ( ≈10 min). Cytotoxicity evaluations by classic cell 
staining procedures after application of an electromagnetic radiation inducing magnetic fluid 
hyperthermia (MFH) show a selective suppression of the EGFR+ cell line. Molecular dynamics and 
docking simulations of the hybrid mAb/Fe@MWCNTs conjugates nicely show how the presence of 
the CNT framework does not sterically affect the conformational properties of the two antigen binding 
regions, further supporting the biochemical findings. 
 
 
Figure 1. Schematic representation of Ab-functionalised Fe@MWCNTs. 
 
 
1. R. Marega, F. De Leo, F. Pineux, J. Sgrignani, A. Magistrato, A. D. Naik, Y. Garcia, L. Flamant, 
C. Michiels, D. Bonifazi, Adv. Funct. Mater. 2013, 23, 3173. 
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Although progress in basic research has led to the design of new generations of anticancer targeted 
drugs with some notable achievements further progress in cancer treatment may be accomplished 
through other existing, but still under-appreciated, therapeutic approaches.1,2 Among these, 
sonodynamic treatment takes advantage from the use of non-thermal ultrasound to activate chemical 
compounds known as sonosensitizers.3 The activated sonosensitizer agent is then able to kill cancer 
cells through the generation of highly reactive products, such as reactive oxygen species (ROS), 
through apoptotic and/or necrotic mechanism. The great advantage of this technique relies on its low 
systemic toxicity, the possibility of highly controlled non-invasive treatments/practices and the non-
occurrence of drug resistance even after repeated treatment. Within this framework, we will present 
the use of biocompatible, polymeric core-shell nanoaparticles (NPs) as multi-functionalized carriers of 
a properly selected sensitizer for in vitro and in vivo tumor treatment.4 In addition, PET and MRI in 
vivo bio-distribution data of our porphyrin loaded nanoparticles will be discussed. 
 
Figure 1. Schematic representation of the sonodynamic treatment mediated by TPPS-NPs and its 
effect on human neuroblastoma SH-SY5Y spheroids volume after different treatment conditions 
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3673. 
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3. Serpe, L.; Foglietta, F.; Canaparo, R. Nanotechnol. Rev. 2012, 1, 173. 
4. Canaparo, R.; Varchi, G.; Ballestri, M.; Foglietta, F.; Sotgiu, G.; Guerrini, A.; Francovich, A.; 
Civera, P.; Frairia, R.; Serpe, L. Int. J. Nanomedicine, 2013, 8, 4247. 
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Lanthanide doped fluorides are interesting hosts for their efficient luminescence in the optical 
(visible and near infrared) regions, make them interesting hosts in modern technological applications, 
such as in biomedical diagnostics. In particular, Er3+/Yb3+ and Tm3+/Yb3+ doped MF2 (M=Ca, Sr) 
nanoparticles (NPs) have been investigated recently for their strong upconversion (anti-Stokes) 
properties [1-4].  
A facile hydrothermal one-step procedure was used to prepare citrate capped CaF2 NPs triply 
doped with Er3+, Gd3+ and Yb3+ or Tm3+, Gd3+ and Yb3+ ions. The obtained NPs are easily dispersible 
in saline or PBS solutions, important property for their use in biological fluids.  The NPs are cubic 
single phase and well size monodispersed, with average sizes of 10-15 nm. The obtained NPs 
transparent colloidal dispersions show strong upconversion emission in the red (around 650 nm) and in 
the NIR (around 800 nm) for the Er3+ doped and Tm3+ doped nanoparticles, respectively, upon laser 
excitation at 980 nm in the 2F5/2 level of Yb3+. Both the excitation and the emitted radiation are close to 
or inside the biological window, suggesting a possible use for in-vitro and in-vivo optical imaging. 
Spin-echo measurements on saline colloidal NPs dispersions have also shown significant proton 
relaxivities, suggesting their possible use as MRI contrast agents. Considering also the high 
biocompatibility, the present NPs are suitable candidates to be efficiently used as nanoprobes for both 
in-vitro and in-vivo multimodal optical and magnetic resonance imaging. 
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Compounds containing high atomic number (Z) atoms like Iodine (Z=53) or Gadolium (Z=63) are 
extensively used in radiotherapy for the increasing dose absorption at tumor site (1). The recent 
explosion of Nanobiotechnology,  an  interdisciplinary  reasearch  area  between  Physics,  Chemistry  
and  Biology,  gives  new  tools  for  developing  new therapeutic  approaches  and  also for the 
improvement of  the  efficacy  of  radiotherapy  by means of a new generation of radiosensitizers 
materials. Gold (Au = 79) Nanoparticles (AuNP) are the most promising candidate to become a 
suitable material for standard treatment in radiotherapy (2).  Although the great success of gold 
nanoparticles in this framework, there is still need to opening new routes for the synthesis of more 
stable and functional nanoparticles.  
In this research work we will discuss some results concerning with the synthesis and the 
characterization of new kind of stable AuNP (Figure 1) stabilized with the organic thiol 3MPS (3-
mercapto-1-propansulfonate) and 1-β-thio-D-glucose (TG). The biocompatibility of the nanostructured 
system are tested with MTT assay in mammalian cell cultures while the internalizzation are followed 
by means of Atomic Absorption Spectroscopy (AAS).    
 
Figure 1. The molecule 3MPS gives waters solubility and 
stabilization to the nanoparticle while the TG gives important 
biological features for the uptake at tumor site. Tumor cell 
indeed have marked anaerobic metabolism, a phenomenon 
called Warburg effect; as consequence, they have a strong 
need for glucose. So the presence of glucose on the surface of 
nanoparticles can increase cellular uptake mainly in cancer 
cell and it can be use for a preferential targeting. 
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In the last 40 years medical imaging has undergone enormous improvements due to the development 
of non-invasive techniques such as computed tomography (CT), magnetic resonance imaging and 
positron emission tomography. Nano-material based contrast agents are quickly becoming valuable 
tools to enhance medical diagnostics for a wide range of in-vitro and in-vivo imaging modalities. In 
this context, gold nanoparticles (AuNPs) show interesting behavior as CT contrast agents owing to 
their high X-ray absorption coefficient and low toxicity.1 Nevertheless, a routine application of AuNPs 
in diagnostics could be achievable only developing a reproducible, high yield and low cost procedure 
for their production. Recently, has been demonstrated that metal vapor synthesis technique (MVS)2 
combined with digestive ripening procedure, allows to prepare monodisperse Au colloids soluble in 
organic phase in large amount and reproducible quality, avoiding the presence of by-products of metal 
salts reduction in solution.2 Here we report a novel synthesis of PEGylated AuNPs by combining MVS 
technique with aqueous digestive ripening process, using CH3O-PEG5000-SH (PEG-SH) as capping 
agent (Scheme 1a). We demonstrate that the developed procedure allowed us to easily obtain a 
sufficient amount of PEG-S-Au acted as safety and efficient CT-contrast agents on a mouse model. 
Moreover, thanks to the innovative combination of MVS technique/surface functionalization, the 
hydrodynamic radius of the engineered PEG-S-Au permitted their efficient renal clearance, still 
retaining a prolonged blood circulation and a stealth capability (Scheme 1b).  
 
 
a)      b) 
Scheme 1. a) Synthesis of PEG-S-Au NPs by combined MVS technique and aqueous digestive 
ripening process; b) X-ray attenuation change versus baseline in function of the time and organ 
accumulation of PEG-S-Au NPs. 
 
 
1. E. Boisselier, D. Astruc Chem. Soc. Rev., 2009, 38, 1759. 
2. a) S.T. Lin, M.T. Franklin, K.J. Klabunde, Langmuir, 1986, 2, 259. b) D. Jose,  J.E. Matthiesen, C. 
Parsons, C.M. Sorensen, K.J. Klabunde, J. Phys. Chem. Lett. 2012, 3, 885. 
 
 NANOMEDICINE Viterbo 2014 SL7 
  
Controlled Photo-Release Drug from Nanoparticles for PDT Applications 
Elisa Lubian,a  Fabrizio Mancin,a  Paolo Scrimin a 
a Department of Chemical Sciences, University of Padova, Via Marzolo 1, 35131, Padova.  
Email of presenting author: elisa.lubian@unipd.it. 
Nanoparticle-based systems have been developed  for nanomedicine applications, in order to improve 
the efficacy of a wide range of drugs, reducing the toxicity for the normal tissues and the long-term 
side-effects. As a matter of fact, “classic” approaches to nanomedicine based on simple or even 
targeted drug-loaded particles, are showing strong limitations and very few nanomedicine agents are 
currently used in healthcare. Likely, dealing with such a complex environment as a living organism 
requires complex tools, capable to adapt their behavior to the different situations they encounter. 
Chemists can substantially contribute to the development of such responsive systems, not only by 
producing new chemical entities or materials, but also by implementing in the nanosystems smart 
behaviors, based on externally triggered chemical reactions. In this context, promising results have 
been accomplished in photodynamic therapy (PDT), a medical cancer treatment based on non-toxic 
photosensitizing drugs that become active producing cytotoxic reactive oxygen species (ROS, in 
particular singlet oxygen) by exposure to light. The major limitation of PDT is the lack of selectivity 
that cause the unfavorable accumulation of photosensitizer (PS) into healthy tissues, causing severe 
side effects. The introduction of the nanotechnology concept in the design of carriers for PDT may 
help in increasing the selectivity. Most important, the production of singlet oxygen combined with a 
photocleavable group offers a phototriggered mechanism that can be exploited in designing 
nanoparticles with photocontrolled behavior. Based on that, we here propose ORMOSIL 
(ORganicallyMOdifiedSILica)1 nanoparticles where a porphyrin PS is covalently loaded through a β-
enamino-ketone spacer, which is cleaved upon singlet oxygen exposure (Figure 1).2 Preliminary 
results show that after light irradiation, the PS is 
released from the nanoparticles, and the extent of 
release increases by prolonging the exposure time. In 
this way, the release of PS may be controlled by an 
external input, and the same concept should be 
applied for releasing therapeutic molecules. Beside 
singlet oxygen sensitive linkers, we also investigated 
polysulphides-based nanoparticles to improve the 
nanoparticles behavior into biological systems. 
The data reported in this work paved the way for the 
creation of smart nanoparticles for theranostic 
applications. 
 
1. F. Selvestrel, D. Segat, E. Reddi, E. Papini, A.J. MacRobert, F. Mancin, Nanoscale 2013, 5, 6106.  
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Figure 1: mechanism of phototriggered 
cleavage. 
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Chemosensors or chemical probes are molecular 
systems capable to recognized and signal the presence 
of an analyte of interest. Such systems, based either on 
molecular structrues or nanoparticles, have attracted 
over the last 30 years a huge interest for biological 
studies since they allow monitoring the levels of 
selected species in living cells with high sensitivity, 
spatial resolution and negligible perturbation. Albeit 
several advantages justify the widespread interest in 
chemosensors, one intrinsic limitation of such an 
approach is that the reliability of a chemosensor 
response depends crucially on its selectivity. Indeed, 
the signal produced arises from a property of the 
chemosensor itself and, as such, it does not provide any 
direct information on the identity of the analyte 
detected. The user must presume he is measuring the 
presence of the desired target, and not of a known or unknown interferent, because he trusts the 
recognition ability of the chemosensor. 
To overcome this problem we recently proposed a new chemosensing method based on NMR and gold 
nanoparticles protected by a monolayer as self-organized receptors.1 This method, relies on the ability 
of monolayer-protected nanoparticles to bind substrates exploiting non-covalent interactions. After 
target recognition, the nanoparticle labels it by NOE magnetization transfer while the signals of the 
other species present are cancelled by a diffusion filter. In this way, only the interacting molecule 
appears in the NMR spectrum allowing its detection and identification. 
In this communication we’ll report on our recent results in the identification of organic anions 
(carboxylates, sulfonates and boronates) and cations (ammonium salts) by NMR chemosensing. The 
attention will be focused on the role played by the nanoparticle monolayer chemical structure in the 
analyte recognition. Indeed, different functional groups can be easily introduced and combined in the 
organic molecules forming the monolayer resulting in the formation of pre-organized and self-
organized binding sites. Selectivity and sensitivity reached allowed the detection and identification of 
metabolites in biological fluids.  
 
 
1. B. Perrone, S. Springhetti, F. Ramadori, F. Rastrelli, F. Mancin 2013, J. Am. Chem Soc. 135, 
11768−11771. 
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Scheme 1. NMR chemosensing 
working scheme. 
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Nanosensing by oligonucleotide optical switches coupled to nanoparticles is a highly promising and 
fascinating strategy for the intracellular detection of a plethora of targets, such as specific mRNA 
molecules and proteins. The use of an antisense oligonucleotide molecular beacon, able to generate a 
fluorescent signal when it hybridizes with the target mRNA, may represent an innovative strategy that 
conjugates the ability of sensing specific mRNA with the pharmacological silencing activity 
preventing the overexpression of proteins associated to pathologic conditions. In cancer research, this 
pharmacological approach has emerged because nonspecific toxicity can be minimized and the 
efficiency of transportation can be enhanced. In this study, we investigated the potential anticancer 
activity of a molecular beacon-oligo-deoxynucleotide (MB-ODN) targeting survivin mRNA and the 
ability of polymethyl-methacrylate (PMMA) nanoparticles (NPs) acting as MB nanocarriers in cancer 
cells. Survivin, a multifunctional protein that plays a role in cancer development and progression [1], 
is overexpressed in cancer cells and undetectable in most healthy tissues. Experiments were performed 
on the human melanoma A375 cell line and human lung carcinoma A549 cells, using human 
monocytes and human dermal fibroblasts (HDFa) as negative controls. MB functionality was firstly 
verified in vitro in solution and after adsorption onto the PMMA NPs. Its functionality and specificity 
were also examined in living cells on the human melanoma A375 cell line and on human monocytes 
as negative control. The MB was firstly transfected by the classical lipid agent, lipofectamine. Real-
time PCR and Western Blot were used to analyse survivin mRNA and protein expression levels, 
respectively. A fluorescence increase in the cytoplasm was observed 1 h after the beginning the 
transfection without evidence of any fluorescence in the extracellular environment. Moreover, no 
fluorescence was observed in transfected cells not expressing survivin. Real-time PCR data and 
Western blot analysis demonstrated that the MB significantly decreased survivin expression in A375 
cells, thus confirming its pharmacological silencing activity. A375 apoptotic cell death was observed 
after 48 and 72 h of MB treatment. PMMA NPs and MB-adsorbed onto NPs were also tested on 
adenocarcinomic human alveolar basal epithelial cells (A549) and human adult fibroblasts in terms of 
cell vitality and internalization. These experiments provided a clear evidence of the subcellular 
distribution of PMMA NPs in living cells as well as of their ability to promote the MB internalization. 
We have shown that oligonucleotide optical switches, together with NPs, can play a fundamental role 
in achieving quantitative information on intracellular events. The conducted analytical characterization 
has demonstrated that they can be used not only as simple on-off elements but also as real theranostic 
agents. 
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Dioleins are well known monomers used in the preparation of highly ordered two or three dimensional 
mesophases in aqueous solution. (1) They could be used to obtain: 1) nanostructures for diagnostic 
applications, when doped with metal-based contrast agents, or 2) nanodevices for drug delivery when 
filled with active drugs, or, finally, 3) theranostics when the two above reported functions (drug and 
contrast agents) are combined together in the same diolein based supramolecular aggregate. 
We describe new nanostructures obtained by co-assembling diolein and the amphiphilic gadolinium 
complex (C18)2-DTPA(Gd), at 90/10 w/w. Pluronic PF127 is added as stabilizer agent. Moreover, 
target selective nanostructures are obtained by adding to the previous formulation a small amount (3% 
w/w) of the amphiphilic folate derivative (C18)2-Peg3000-folic acid. 
The obtained nanostructures are loaded with Doxorubicin to give, respectively, theranostics and target-
selective theranostic agents for IGROV-1 cells overexpressing folate receptors. 
All aggregates are fully characterized for their structure by DLS and TEM, for drug loading ability and 
for doxorubicin release. 
Relaxometric studies suggests their potential application in MRI as target selective contrast agents, 
while in vitro experiments (citotoxicity studies and confocal microscopy images) confirm that target 
diolenin based nanostructures show a higher uptake and citotoxicity versus IGROV-1 cells respect to 
liposomial doxorubicin.   
   
 
 
Figure 1. Schematic representation of [(C18)2DTPA(Gd)] and 
[(C18)2Peg3000-FA] monomers mixed with the commercially available 
diolein (DO) and the Cryo-TEM image of the resulting nanostructures 
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MicroRNAs (miRNAs) are small noncoding RNAs involved in gene regulation. Dysregulated miRNA 
levels are typical of pathological conditions such as cancer.1 Therefore, the detection and 
quantification of miRNA expression levels has high clinical relevance and the development of new, 
direct, sensitive, and rapid quantification strategies is essential for the exploitation of these biomarkers 
in diagnosis and prognosis. 
We have developed a sensitive assay for the absolute quantification of miRNAs based on enzymatic 
processing of DNA-functionalized gold nanoparticles (AuNPs), resulting in a fluorescence signal 
(Figure 1).2 The limit of detection of our assay is as low as 0.2 fmol of miRNA, which corresponds to 
approximately 100 copies/cell. The assay is direct, avoiding the conversion of miRNA into cDNA, and 
technologically easy to implement, not requiring thermal cycling, and can be completed in only 2  5 
hours. 
In this contribution, we will demonstrate why and how the molecular design of our DNA-AuNP 
probes is essential for the efficiency of this sensing platform. We will also present the application of 
our assay to the determination of hsa-miR-21 and hsa-miR-203, representing high- and low-abundance 
miRNAs respectively, in samples of total RNA extracted from cell cultures. The sensitivity, simplicity 
and rapidity of our strategy hold great promises for establishing this assay as valuable alternative for 
absolute and direct miRNA quantification. 
 
Figure 1. Assay strategy: the fluorescence of labeled 
DNA-probes is quenched by their vicinity to the AuNP 
surface. Enzymatic cleavage of the DNA-probes is 
triggered by hybridization with target miRNA and results 
in fluorescence recovery. The enzyme duplex specific 
nuclease (DSN) allows for miRNA target recycling. 
 
 
1. Di Leva, G.; Croce, C. M. Trends Mol. Med. 2010, 16, 257. 
2. Degliangeli, F.; Kshirsagar, P.; Brunetti, V.; Pompa, P. P.; Fiammengo, R. J. Am. Chem. Soc. 2014, 
136, 2264. 
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Layer-by-layer (LbL) assembly is a very simple and versatile technique for the fabrication of 
nanostructured architectures with high molecular order. The assessment of this process depends 
mainly on adsorption of polyanion–polycation polymers alternatively assembled onto the  surface of 
template. In spite of its important in biomedical application LbL process is not completely understood 
because it depends mostly on template for building multilayers. Most used templates are derived from 
inorganic (manganese carbonate, calcium carbonate and cadmium carbonate) and organic (melamine 
formaldehyde and silicon oxide) materials. The dissolution of these templates in solvents might affect 
capsules assembly. Additionally, solvent like EDTA can dissolve easily curcumin from CaCO3 carrier 
after pre-loading during core removal. Therefore our aim is to breakdown curcumin to nano-scale and 
used it as bio-template for building layer-by-layer assembly onto its surface . 
Curcumin  nanoscale template provides unique properties for carrier: it can be encapsulated by using 
LbL, keeping its physical and chemical properties. Since core removal is not needed,  this procedure 
keeps curcumin without releasing it. Moreover, curcumin nanoscale template have allowed us to 
create capsules after curcumin removal. Capsules size and morphology were investigated by using 
SEM and TEM. The charge of curcumin template and layer-by-layer assembly was assessed by zeta 
potential. The cytotoxicity of curcumin bio-template nanocarrier was also investigated confirming its 
potential as novel template for nano-drug delivery. 
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Despite the design of several anticancer drugs that induce cancer cell death or the retardation of their 
growth, the success of pharmacological treatment is often hampered by the onset of the drug 
resistance. Several mechanisms are used by tumor cells to protect themselves from the antitumor 
compounds currently used in the clinical setting. New delivery systems including liposomes have been 
developed to circumvent drug resistance. In fact, drug encapsulation in liposomes markedly changes 
pharmacokinetic and pharmacodynamic properties and reduces systemic toxicity; moreover, drug is 
prevented from early degradation and/or inactivation[1].To enhance the antitumor efficacy of liposomes 
encapsulating anti-cancer agents, we have used liposomes externally conjugated with the 19 residues 
of gH625 peptide, previously identified as a membrane-perturbing domain in the gH glycoprotein of 
Herpes simplex virus type I [2,3]. We have evaluated the growth inhibition of either wild type (A549) or 
doxorubicin (Doxo)-resistant (A549 Dx) human lung adenocarcinoma cell line treated with increasing 
concentrations of liposomes encapsulating Doxo (LipoDoxo), liposomes encapsulating Doxo 
conjugated with gH625 peptide (LipoDoxo - gH625 ), empty liposomes (Lipo) or free Doxo for 72h. 
The growth inhibition was assessed by MTT viability assay. Thereafter, we have studied the Doxo 
uptake in both cell lines by spectrophotometric assay and flow cytometry. We have also evaluated the 
cell death mechanisms induced by 50% growth inhibitory concentrations (IC50) of pharmacological 
agents and the oxidative stress status by flow cytometry. We found that the growth inhibition induced 
by LipoDoxo-gH625 was more potent than that one caused by LipoDoxo with an IC50 of 2.7 and 5µM, 
respectively, in A549 Dx cells. Interestingly, empty liposomes had no cytotoxic effects. The data on 
cell growth inhibition were paralleled by an increased uptake of Doxo induced by LipoDoxo - gH625 
of compared to LipoDoxo in A549 Dx cells. These data were confirmed by flow cytometric analysis. 
Moreover, cytometric analysis revealed that the antiproliferative effects of each drug treatment were 
mainly due to the induction of apoptosis. Moreover, the data obtained on oxidative stress suggested a 
greater internalization of LipoDoxo-gH625 than LipoDoxo after 72h of treatment. In conclusion, we 
have demonstrated that the functionalization of liposomes with gH625 viral peptide increases Doxo 
accumulation in Doxo resistant A549 cell line and this effect is paralleled by an increased cytotoxicity.  
 
 
1. M. B. Bally et al, Biochim. Biophys. Acta Biomembr.,1990, 1023, 133. 
2. A. Falanga et al, Nanomedicine,2011,7, 925. 
3. R. Tarallo et al, Chem. Eur. J., 2011, 17, 12659 
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The possibility to control specific cell functions by modulating the polymer properties represents a key 
step on material science in tissue engineering. This work reports the promising perspectives of poly(L-
lactic acid), (PLLA) based nano-engineered biomaterials and their relevance in tissue engineering 
(1,2). The effects of nanocomposite properties are here extensively investigated and reported in terms 
of stem cell responses. PLLA nanocomposite films were obtaining by solvent casting technology. 
Multiwalled carbon nanotubes (MWCNTs) were used as conductive nanostructures (0-3wt.%). 
Morphological, mechanical, electrical and surface properties of PLLA/MWCNTs nanocomposites 
were investigated and correlated to the MWCNT content. Human bone marrow mesenchymal stem 
cells (BM-MSCs) were obtained from washouts of the medullary cavities of the femurs, while human 
umbilical cord mesenchymal stem cells (UCMS) were isolated from umbilical cord. Stem cell/material 
interactions were evaluated analyzing the plasma membrane integrins, cytoskeleton organization (α-
tubulin/F-actin), nuclear laminin A/B of seeded stem cells. PLLA conductive nanocomposite films 
show the formation of a three-dimensional nanotube network in the percolated formulations. 
Interestingly hBM-MSCs and hUCMS differently interacted when seeded on nanostructured PLLA 
based biomaterials. While BM-MSCs showed a canonical mesenchymal morphology with F-actin-
containing fibers arranged on the major cellular axis, UCMS changed their fibroblast-like morphology, 
acquiring a sphere-like structure (Figure 1). Our data demonstrates that nanostructured PLLA is a 
good candidate to study the effect of the biomaterial physical properties on the stem cell fate. The 
physical and chemical properties of the PLLA, including size, shape, mechanical properties, surface 
texture, etc. can regulate biological responses and provide mechanical stimuli to stem cells. The 
identification of critical mechano-sensitive molecules and cellular components that contribute to the 
mechanotransduction response is basic for medicine regenerative applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. FESEM images of UCMS (a) and BM-MSCs (b) grown on PLLA nanocomposite. 
1. D’Angelo F, et al. Biomacromolecule, 2012, 13, 1350. 
2. Armentano I, et al. Progress in Polymer Science, 2014, 38, 1720. 
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Oligomeric plant polyphenols (tannins) are present in many foods, botanicals and nutritional 
supplements. A growing body of research indicates that increased dietary consumption of tannins is 
associated with a decreased risk of diseases such as coronary artery disease, cancer, urinary tract 
infections, and ulcers. 
Chitosan (a random co-polymer of N-acetyl-D-glucosamine and N-glucosamine) binds to negatively 
charged tannins by an electrostatic interaction driven by its positively charged amino group. This 
interaction allows developing stable hybrid nanoparticles via ionotropic gelation with tripolyphosphate 
(TPP), suitable as a therapeutic controlled release system for urinary tract infections.  
We study the effect of chitosan-GSE (grape seed extract) hybrid nanoparticles on the invasion of 
Caco-2 cells by Uro-pathogenic Escherichia coli (UPEC) strain 5011, supplied by the UW-University 
Hospital, Madison, WI, USA.  
When the pathogen was exposed to a chitosan nanoparticle preparation, no disruption of the normal 
structure of flagella is observed (Fig. 1, Panel B).  When the pathogen was exposed to the tannin-
chitosan hybrid nanoparticles, extensive coating and cross-linking of flagella on multiple cells is seen 
(Fig. 1, Panel C).  It was also noted that this interaction created numerous aggregates of UPEC.  Figure 
1 (panel D) is a SEM micrograph of the tannin-chitosan hybrid nanoparticles alone.  These results 
indicate that the GSE tannin-chitosan hybrid nanoparticles physically coat the flagella of UPEC, which 
in turn prevents invasion of the intestinal epithelial cell. 
 
 
Figure 1. SEM micrograph exploring the interactions of GSE-chitosan composite nanoparticles with 
UPEC 5011 and its effect on cell invasion.   
 
 
1. J.D. Reed, C.G. Krueger, S. Madrigal-Carballo, USPTO, 2011, US 2011/0059162 A1. 
2. S. Madrigal-Carballo, S. Lim, G. Rodríguez, A.O. Vila, C.G. Krueger, S. Gunasekaran, J.D. Reed. 
(2010). J. Functional Foods, 2010, 2, 99.  
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Cancer chemotherapy is often effective only on drug sensitive tumor cells, leaving unaltered a high 
portion of drug resistant cells. Consequently, patients with osteosarcoma that do not respond to 
therapy for drug resistance induction, have metastatic diseases and a poor diagnosis. For these reason, 
it is very urgent to find efficacy therapeutic combinations with few side effects. In vitro studies 
demonstrated that voacamine (VOA), a bisindolic alkaloid isolated from Peschiera fuchsifoliae plant, 
enhanced cytotoxic effect of doxorubicin (DOX) on drug resistant tumor cells, such as osteosarcoma 
and melanoma.1,2 The chemosensitizing effect of VOA on osteosarcoma cells was due to the P-gp 
inhibition, the main efflux pump responsible of drug resistance.3 Moreover, the dose of VOA used to 
sensitize tumor cells to DOX was not toxic to normal cells.2  These properties make VOA an attractive 
candidate for the development of targeting liposomal formulations more biologically effective. 
The cationic liposomes VOA may increase the biomedical applications favoring its solubility in water, 
increasing accumulation in target tissues, and reducing its accumulation in healthy tissues. We 
included VOA into liposomes composed of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), 
gemini surfactant, and cholesterol by a remote loading technique. Preliminary flow cytometric analysis 
using liposomes labeled with fluorescent probe (NBD) clarified the best conditions of treatment 
(concentration and exposure time) on osteosarcoma resistant cells (U-2/OS DX). Trypan blue uptake 
assay by flow cytometry indicated that these formulations induced transient plasma membrane 
permeabilization. Then we evaluated the chemosensitizing effect of VOA-loaded in liposomes against 
VOA-free on U-2/OS DX cells. DOX intracellular uptake, assessed by flow cytometry, was higher in 
liposomes-VOA than free-VOA treated cells. MTT assay showed a growth inhibition of about 10% in 
cells pre-treated with VOA loaded into liposomes than VOA-free. Optical microscopic evaluations, 24 
h after recovery in drug free medium, showed that osteosarcoma cells pre-treated with liposomes-
VOA before DOX treatment were dead compared to cells treated with free-VOA and DOX. UIC2 
flow cytometry shift assay showed that liposomes do not alter the functionality of P-gp, and that VOA 
loaded into liposomes exerts the inhibitory effect against P-gp as the free VOA.  
These results showed that the encapsulation of the VOA into liposomes improved its delivery in 
resistant tumor cells and its chemosensitizing efficacy. Further studies will clarify if there are different 
molecular targets involved in VOA loaded liposomes and VOA free. 
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Arancia. Int. J. Oncol., 2005, 27, 1597. 
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During the last decade the employment of collagen-based scaffolds in the biomaterials’ field has been 
intensively growing. Collagen is well-known in tissue engineering for its excellent biocompatibility, 
low antigenicity and capacity to regenerate different tissues: bone and cartilage, , skin, and peripheral 
nerves. Peripheral nerve and spinal cord regeneration are very important topics in regenerative 
medicine. Conventional tissue engineering strategies utilize acellular biodegradable scaffolds  
combined with the systemic administration of bioactive molecules [1] (i.e. neurotrophic factors) to 
promote bio-mimicking processes of tissue regeneration. However, this approach has several 
limitations [2]. One of the most common methods to achieve controlled and localized release of 
biomolecules is to incorporate them within biomaterials during the scaffold’s fabrication [3]. 
According to this approach, the scaffold degradation affects the biomolecule release rate over a 
prolonged time period. In this study collagen-based scaffolds showing an oriented porous structure, 
suitable for peripheral nerve regeneration, were embedded with biodegradable polymeric nanoparticles 
loaded with fluorescent active biomolecules. Confocal laser scanning microscopy (CLSM) analysis 
allowed to assess the degradation of the nanoparticles in physiological conditions and the release 
kinetic of biomolecules from the scaffold. 
Scaffold synthesis. An aqueous collagen suspension was prepared and added with the nanoparticles. 
Several concentrations of nanoparticles were tested. The final suspensions were cast into tubes and 
processed by means of uniaxial freezing and freeze-drying, in order to obtain porous collagen-based 
scaffolds with longitudinally oriented pores. EDAC crosslinking method was also performed to 
preserve the structure of the collagen matrix. Characterization experiments. The resistance to thermal 
degradation was evaluated in vitro, by incubating the scaffolds in PBS at 37°C. At different time 
points the scaffolds were analysed by means of CLSM. 
CLSM allowed to assess the distribution of the nanoparticles loaded with a fluorescent antibody inside 
the collagen scaffolds by detecting the fluorescence signals arising from the fluorophore (FITC). Scans 
at different heights and at the transversal sections of the scaffolds were collected in order to define the 
3D localization of the nanoparticles. The nanoparticles were embedded inside the collagen matrix and 
localised to the inner regions of the tubular collagen sheets for up to 30 days. The concentration of 
nanoparticles seemed to affect their distribution within the scaffold structure: at lower concentrations, 
they were homogeneously distributed within the collagen matrix, whereas at higher concentrations the 
nanoparticles formed large clusters, likely due to strong interparticle interactions. This in turn 
influenced the degradation time of the nanoparticles. Indeed, when using high nanoparticle 
concentration, their degradation was slowed and the fluorescent signal was still well visible in the 
scaffold after 30 days. Another critical parameter is the capacity of the scaffolds to maintain the 
oriented porous structure. We observed that after two weeks in PBS collagen scaffolds started to 
degrade, but still maintained their lamellar-like structure after 30 days. 
The experimental results from the current study show that accurate control of the crosslinking 
treatment was essential to preserve the structure of collagen. Further, the degradation kinetic of the 
nanoparticles seems to be in the optimal time window to have complete regeneration in peripheral 
nerves [4].  
1. Sun W. et al., J. Biomed. Mater. 2010;92:887-895. 
2. Friess W. et al., Eur J Pharm Biopharm 1998;45: 113-136. 
3. Xu C. et al., Sci. World J. 2012 (2012), pp. 1–10. Sivolella S. et al., Int. J. Mol. Sci. 2014;15(2): 3088-3117 
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Glioblastomas are the most common and aggressive brain tumors in adults. The treatment of central 
nervous system tumors is limited by the presence of blood–brain barrier (BBB), which commonly 
prevents many drugs or infectious agents from entering the brain (1). Currently the chemotherapy drug 
used is temozolomide (TMZ) in combination with radiotherapy but glioblastoma cells develop 
resistance to this drug. 
Zoledronic acid (ZOL) is a drug whose potent anticancer activity is limited by its short half-life and 
accumulation within bone (2). On these bases, there is a need to develop a delivery system to avoid 
ZOL accumulation into the bone, thus improving extra-skeletal bioavailability. Nanotechnology 
utilized to enhance drug activity consists in PEGylated nanoparticles (NPs), self-assembling, obtained 
by mixing an aqueous solution of calcium phosphate with ZOL (CaPZ NP) and cationic liposomes (3). 
The functionalization of these nanoparticles with transferrin (Tf) could allow their crossing tight 
endothelial cells of BBB by internalization transferrin receptor (TfR) –mediated. 
The encapsulation of ZOL in Tf functionalized NPs (Tf-NPs) caused higher in vitro cytotoxic activity 
than free ZOL on LN-229, U-373 MG and in U-87 MG glioblastoma cell lines. Same strengthening of 
Tf-NPs-ZOL was obtained in in mice intramuscularly bearing glioblastoma tumors. 
Moreover, we performed experiments with TMZ, a gold standard for the treatment of glioblastomas 
and the three cell lines showed resistance to drug because the half maximal inhibitory concentrations 
(IC50) were very high (95 µM for U-87 MG, 110 µM for U-373 MG and 176 µM for LN-229 cells). 
On these bases, we used radiotherapy in combination with Tf-NPs to overcome resistance to TMZ and 
to potentiate ZOL activity.  
We evaluated the effects of different radiotherapy dosages with concomitant treatment of 
functionalized NPs-ZOL or free ZOL on growth inhibition of glioblastoma cell lines by MTT assay. 
Preliminary results showed that drug activity was increased by radiotherapy. Moreover, the growth 
inhibition induced by radiation therapy alone did not reach 50% even at higher dosages (12 Gy). 
In conclusion, the use of nanoparticles represents a new strategy for the delivery of drugs and these 
experiments lay the foundation for a more efficient cancer therapy. 
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3. G. Salzano, M. Marra, M. Porru et al., Int J Pharm, 2011, 1-2, 292. 
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Multiple layers of host proteins on nanoparticles (NPs) influence the bio-activity of nanotheranostics. 
Some proteins stably bind to NPs (hard corona), while others interact reversibly (soft corona). We 
characterized the human plasma (HP) proteins bound to amorphous SiO2-NPs (Ø 26 nm), and studied 
their effect on the NPs interaction with human lymphocytes, monocytes and macrophages. Histidine 
Rich Glycoprotein (HRG), a plasma 64 KDa  protein having a characteristic Histidine Rich Region 
(HRR), is a major component of the SiO2-NPs hard corona in excess HP, together with minor amounts 
of the HRG homologous High Molecular Weight Kininogen (HMWK). HRG competes with other HP 
proteins for the NPs surface so inhibiting their uptake by macrophages. In lymphocytes and monocytes 
several plasma proteins can interchange in this inhibitory activity. Upon depletion of HRG from HP, a 
heterogeneous hard corona forms including fibrinogen, HDLs, LDL and VLDL , IgG, Human serum 
albumin and complement H factor. HRG is the main component of the HP-derived SiO2-NPs hard 
corona (Figure 1), uniquely conferring to these particles the ability to evade macrophages capture.  
 
 
 
Figure 1. Scheme of hard corona coated SiO2-NPs in human plasma 
 
 
 
 
 
 NANOMEDICINE  Viterbo 2014 SL20 
  
Transferrin-conjugated self-assembled nanoparticles incorporating 
ZOL as a tool for the targeting of glioblastoma  
Silvia Zappavigna,a  Amalia Luce,a  Manuela Porru,b  Sara Lusa,c  Giuseppina Salzano,c  Simona 
Artuso,b  Antonella Stoppacciaro,b  Giuseppe De Rosa,c  Carlo Leonetti,b  Michele Caragliaa. 
aDepartment of Biochemistry, Biophysics and General Pathology, Second University of Naples, via 
Costantinopoli 16, 80138, Naples, Italy; bExperimental Oncology Laboratory, Regina Elena Cancer 
Institute, via delle Messi d’oro 16, 00138,Rome, Italy; c Department of Pharmacy, University of 
Naples Federico II, via Montesano 49, 80131, Naples, Italy;  
Email of presenting author: silvia.zappa@libero.it. 
Glioblastomas are highly aggressive brain tumors of adults with poor clinical outcome. The blood–
brain barrier (BBB) is the most important limiting factor for the development of new drugs and drug 
delivery for the central nervous system (CNS). Different methods have been used to facilitate the drug 
transportation into the brain (1). Here, we propose a new strategy to treat glioblastoma based on self-
assembling nanoparticles (NPs) encapsulating Zoledronic Acid (ZOL) (2). In order to improve the 
internalization rate of ZOL into the brain tumor, these NPs have been functionalized with transferrin 
(Tf), maintaining the possibility to prepare them before use by self-assembling procedure. NPs-ZOL-
Tf have been assessed on the glioblastoma cell line U373MG-LUC that showed a refractoriness in 
vitro to anti-cancer agents conventionally used for the clinical treatment of glioblastoma, namely 
temozolomide (TMZ) and fotemustine (FTM). NPs-ZOL-Tf treatment resulted in higher in vitro 
cytotoxic activity than free ZOL. However, the potentiation of anti-proliferative activity of NPs-ZOL-
Tf was superimposable to that one induced by NPs-ZOL (not armed with Tf). On the other hand, NPs-
ZOL-Tf showed a higher antitumor efficacy if compared with that one caused by NPs-ZOL in 
immunosuppressed mice intramuscularly bearing U373MG-LUC xenografts, inducing a significant 
tumor weight inhibition (TWI) of 41%, a tumor growth delay (T-C) of 10 days and an increase of mice 
survival (ILS) of 23%. Interestingly, while NPs-ZOL treatment induced a stable disease in 1/6 treated 
mice, NPs-ZOL-Tf produced a complete tumor regression in 1/6 treated mice. The experiments 
performed on mice with intracranial U373MG-LUC xenografts confirmed the efficacy of NPs-ZOL-
Tf. Indeed, NPs-ZOL administration elicited the stabilization of the disease in 2/8 treated mice and an 
ILS of 13%, NPs-ZOL-Tf treatment resulted in an improved therapeutic efficacy as 3/8 mice showed a 
stable disease and, impressively, one mouse displayed a complete tumor response. Moreover, an ILS 
of 23% was observed. These effects were paralleled by a higher intratumour localization of 
fluorescently-labeled-NPs-Tf both in intramuscular and intracranial xenografts. In conclusion, our 
results demonstrate that the encapsulation of ZOL increases the antitumor efficacy of this drug in 
glioblastoma through the acquisition of ability to cross the BBB, thus suggesting the application of this 
strategy in clinical setting.  
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In this work, we demonstrated two important aspects of this new nanostructured GO, highlighted 
below: 1. The high biocompatibility of GO with human cells1. The human endothelial-like 
immortalized cell line EaHy926, derived from the fusion of human umbilical vein endothelial cells 
(HUVEC) with the bronchial carcinoma cell line A549, and expressing an endothelial-like phenotype, 
after “in vitro” exposure for 24hrs to different concentrations of GO (0,2-20µg/ml) did not show any 
significant morphological or functional modification. The cell viability was not affected. TEM and 
Confocal Laser Scanning Microscopy (CLSM) analysis demonstrated the uptake of GO into cells and 
their localization in the cytoplasmic compartment; 2. GO can be “in vitro” conjugated to several 
bioactive molecules, such as hormones, cytokines or bio-mediators, so that they can be easily 
delivered into cells. Thus could be particularly relevant for those agents which normally play their 
action exclusively through the linking to specific receptors. In this study, we also shown the possibility 
to manipulate spatially inhomogeneous, non-uniform conductivity patterns across a flake of graphene. 
In this way, the auto-fluorescence into the total reflectance phenomena for GO, performed by using 
the Confocal Laser Scanning Microscopy (for “in vitro” and “in vivo” measurements), could be very 
promising for molecular imaging in Nanomedicine2. 
 
                       (a)               (b)  
 
Figure 1. CLSM images of (a): Ea.Hy926/SWCNTs (Single-
Wall Carbon Nanotubes, as graphene precursors3) treated cells; 
(b): Ea.Hy926 /GO.  
 
 
1. A. C. Neto, New Scientist Volume, 2012, 214, 4. 
2. H. Wen, C. Dong, H. Dong, A. Shen, W. Xia, X. Cai, Y. Song, X. Li, Y. Li, D. Shi, Small, 
2012, 8, 760. 
3. F. Valentini, et al.; Carbon, 2010, 48, 2596. 
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Magnetic nanoparticles (MNPs) are bringing novel and promising ways to treat deadly diseases such 
as cancer. They have multiple applications that range from magnetic hyperthermia, localized drug 
delivery and release, to tissue engineering and new materials. Magnetic nanoparticles can be heated 
when they are exposed to alternating magnetic fields (AMF) due their properties. Iron oxides 
nanoparticles (Fe2O3/Fe3O4) are currently one of the magnetic materials most used as heating agents. 
The physical properties of the core material and chemical properties of the coating surface are the key 
parameters for successful biological applications. Colloidal stability against precipitation and 
agglomeration of the constituent nanoparticles is a key factor to keep the heating efficiency of the 
ferrofluid in the long term. Within the scope of the ongoing collaboration between nanoScale 
Biomagnetic (nB) and the Instituto de Nanociencia de Aragón (INA) we have developed a highly 
stable water-based colloid composed of PEI-coated Fe3O4 magnetic nanoparticles that is commercially 
known as Magno, which specific goal is to serve as a basic elementary supply for many magnetic 
heating procedures, including in vitro and in vivo experiments. We have exploited and studied 
Magno’s physical and chemical properties to track the evolution of the heating efficacy of the particle, 
particularly measuring the specific power absorption (SPA) along one year using a DM1 device, 
delivering an AMF up to 24 kA/m and frequencies 260 < f <830 kHz. We demonstrated that the SPA 
parameter is highly sensitive to minute changes in the colloidal state of the samples calculating the 
value according several fit methods. This fact is particularly relevant in relation to the biological 
applications magnetic heating of nanoparticles, like magnetic hyperthermia or magnetically induced 
drug release due to the known fact of that MNPs tend to form aggregates once they penetrated the cell 
membrane and remain inside the cell. 
 
 
 
 
 NANOMEDICINE Viterbo 2014  IR2 
  
Nanoparticle-based approaches to push the limits of Surface Plasmon 
Resonance imaging for the detection of diagnostic biomarkers  
Elodie Ly-Morin 
HORIBA Scientific, Palaiseau, France 
Email of presenting author: elodie.ly-morin@horiba.com 
Diagnostic biomarkers for neurological disorders, cardiovascular diseases and cancer are often in low 
abundance in bodily fluids, presenting many challenges for their detection. 
Surface Plasmon Resonance imaging (SPRi) is a label-free optical technology used to monitor 
biomolecular interactions in real-time and in a multiplex format. It is thus possible to detect 
specifically and simultaneously multiple molecules from the same sample. SPRi is compatible with the 
analysis of complex solutions such as bodily fluids which makes it an ideal technique for the 
development of fast diagnostic tests. 
Nanoparticle-based sandwich assays create a mass loading effect on the SPRi sensor chip surface, 
generating a significant enhancement of the SPRi signal. This strategy was used to push the limits of 
SPRi for the detection of ultra-low levels of ssDNA (down to 100 fM) and C-reactive protein in 
human serum (down to 43 aM). 
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This communication shows the ways in which nanoparticles, originated by the biodestruction of 
plastic materials carried out by microbes, are able to access human organs by means of microorganism 
acting as facilitators. The aim of this work is to highlight how electron microscopy is a fundamental 
and versatile technique of high value in the investigation of the interaction between bacteria and 
polymeric materials. 
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The use of nanoparticles in drug delivery continues to grow rapidly. Nanoparticles offer excellent 
pharmacokinetic properties, controlled and sustained release, and targeting of specific cells, tissues or 
organs. When considering a nanomaterial drug delivery system, size is clearly a key parameter as it 
directly influences the processes of delivery, uptake, degradation and clearance from the body.  
Complementary to classical light scattering techniques, NTA (Nanoparticle Tracking Analysis) allows 
nanoparticles to be sized on a particle-by-particle basis, enabling high resolution profile. On the same 
analysis, NTA also delivers concentration measurement through a direct count (particles per ml), 
helping the understanding of aggregation or other particle behaviour in complex systems. Finally, a 
fluorescence mode allows differentiation of suitably labelled particles.  
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Voacamine, a bisindolic alkaloid extracted from Peschiera fuchsiaefolia, displays several 
pharmacological properties, such as cardiotonic effect, antimalarial activity and enhancement of the 
cytotoxic effect of doxorubicin (DOX) on multidrug resistant tumour cells 1. 
The inclusion of VOA in liposome formulations could increase its potential application by i) rendering 
it soluble in water, ii) controlling its pharmacokinetics and biodistribution, iii) increasing its 
accumulation in target tissues and iv) avoiding or reducing its accumulation in healthy tissues, thus 
reducing toxic effects.  
Actually the two tertiary amine groups of VOA could be exploited to load it in the internal aqueous 
compartment of liposomes by a remote loading technique. 
Here we report the inclusion of VOA into gemini based cationic liposomes by a remote loading 
technique where an ammonium sulfate gradient generates a transmembrane pH imbalance necessary a 
transmembrane pH imbalance necessary to trigger loading of VOA 2. 
The gemini surfactant 1, was chosen as cationic component of liposomes, due to the fact that it is 
characterized by low toxicity and was shown able to attribute to phospholipid formulations high 
delivery efficacy 3. 
VOA loaded in liposomes composed of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine), gemini 
and cholesterol (in a 1.6:0.4:1 ratio) with high efficacy was evaluated against free VOA on an 
osteosarcoma cell line. 
 
 
 
Voacamine       1 
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Hepatocellular carcinoma (HCC) is the sixth most common cancer worldwide and the third leading 
cause of cancer-related deaths. For the treatment of HCC several drugs are under development, but the 
only one with proven survival benefit is sorafenib. This agent is a multikinase inhibitor that blocks Raf 
signaling and VEGF, PDGF and c-Kit. It has antiproliferative and antiangiogenic activity and delays 
tumor progression [1,2]. Moreover, systemic tumor-targeted gene delivery is attracting increasing 
attention as a promising alternative to conventional therapeutic strategies. At this purpose a large 
number of viral and non-viral vectors have been studied and applied as systems of stable transfection 
with low toxicity. Although cationic polymers and liposome are promising systems, solid lipid 
nanoparticles (SLN) have been recently proved to be a really useful vehicle for gene therapy [3,4]. The 
aim of this work was to design and to obtain cationic SLNs containing sorafenib capable of forming 
complexes with siRNA and DNA plasmid for the treatment of HCC, in order to combine the effects of 
drug and nucleic acids. 
The physical binding between cSLN and nucleic acids was confirmed by the study of complexes’ zeta 
potential values that became more positive as higher was the amount of cSLN and via the 
electrophoretic mobility of the samples in agarose gel 0.8%. Transfection studies on different tumor 
cell line are in progress. 
 
 
Figure 1. Cationic SLN-DNA interaction. 
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Skin wound healing is a complex and highly-regulated sequential biological process, which is 
temporally divided into three distinct phases: early acute exudative, fibro-proliferative, and tissue 
remodeling. A variety of cytokines, growth factors, and chemokines are known to be involved in 
different aspects of the skin wound healing process.  
In the present work we investigated a single active wound dressing model composed by a water 
soluble chitosan derivate, N-methacrylate glycol chitosan (MGC), cellulose fibers as support, and a 
water soluble drug, 2% eosin. The samples impregnated with the antibacterial agent were tested in a 
wound healing animal model, measuring the activity of the pro-inflammatory cytokine IL-6 in the 
early acute exudative phase. 
Mice (male C57BL/J6, gr. 22-24) were anesthetized with isoflurane 1.5–2% from a nose cone. After 
shaving the dorsal hair and cleaning of the exposed skin, one full-thickness (including the Panniculus 
carnosus) excisional wound was punched in the middle of the dorsum (Gerharz et al., 2007).  
The wound induced a significant increase of IL-6 levels 6 hours after its induction. When the wound 
area was covered with the polymer impregnated with eosin, IL-6 levels were significantly reduced by 
at least 50%, suggesting a potent anti-inflammatory action of the wound dressing.     
Our preliminary data demonstrate that the polymer’s application is safe and biocompatible for the 
animal skin and it is able to release eosin within the first 6 hours after the wound induction. 
Furthermore, both polymer and eosin reduce IL-6 expression in this mouse model of punch wound. 
Further studies are ongoing to better clarify the combined action of polymer plus eosin in the wound 
healing model. 
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The main objective in the development of new liposomes as drug delivery systems is obtaining a 
control over their biodistribution, thus achieving selective and sufficiently high localization of their 
cargo at disease sites such as tumors and inflamed tissues. A complete understanding of the liposome 
parameters that might control internalization and intracellular trafficking pathways is fundamental to 
enable optimal nanomedicine design. 
It was reported that the cell uptake and the intracellular distribution of a photosensitizer delivered by 
liposomes composed of 1,2-dimyristoyl-sn-glycero-3-phosphocholine, DMPC, and one of two 
stereoisomeric cationic gemini amphiphiles, 1a and 1b is controlled by the stereochemistry of the 
gemini component 1.1  
Herein we report on the molecular dynamic simulation of DMPC/1a and DMPC/1b lipid bilayers 
aimed at giving an atomistic description of the molecular organization in the two diastereomeric lipid 
bilayers. The results obtained show that the different orientation of polar groups at the surface of lipid 
bilayers controls the organization and the mobility of the water bound to the lipid systems, parameters 
that could indeed influence the interaction with biological systems. 
 
 
 
 
 
 
 
 
 
 
Figure 1. Diasteromeric gemini amphiphiles. 
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We have developed cationic liposomes, formulated with 1,2-dimyristoyl-sn-glycero-3-
phosphocholine, DMPC, and one of two stereoisomeric cationic gemini amphiphiles, 1a and 1b, to 
deliver a photosensitizer to cancer cells. The stereochemistry of the gemini component was shown to 
affect cell uptake of the photosensitizer, as well as its intracellular distribution.1 
Herein we report a detailed biological investigation aimed at elucidating the pathways of 
internalization and the intracellular trafficking of DMPC/1a and DMPC/1b liposome formulations. 
The study was carried out on human and murine glioblastoma cells by using inhibitor assay along with 
flow cytometry and laser scanning confocal microscopy (LSCM). Transmission electron microscopy 
(TEM) observations on ultrathin sectioned samples and on PT-C replicas by freeze-fracturing 
contributed to elucidate at higher resolution the intracellular trafficking of the two liposome 
formulations. 
The results obtained demonstrated that the stereochemistry of the gemini component controls the 
subcellular fate of the two liposome formulations. Actually, after binding to the plasma membrane, 
DMPC/1a liposomes are internalized trough caveolae-coated vesicles to be preferentially transferred 
to early endosomes. On the other hand, clathrin-mediated endocytosis of DMPC/1b leads to the 
formation of early endosomes, which are acidified and fuses with prelysosomal vesicles to give rise to 
late endosomes and, finally, to lysosomes. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Diasteromeric gemini amphiphiles used in the liposome formulations. 
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INTRODUCTION: Glioblastoma (GBM) is the most common brain cancer in adults. It is also, 
unfortunately, the most aggressive type, characterized by rapid progression and poor prognosis, and 
the least responsive to therapy 
Protein isoaspartyl carboxyl O-methyltransferase (PCMT1; EC 2.1.1.77) is a S-adenosylmethionine-
dependent methyltransferase, which specifically recognizes and methyl esterifies the free α-carboxyl 
groups of isoaspartyl residues, arising from asparaginyl deamidation. The tissue distribution of 
PCMT1 is ubiquitous, although maximal expression has been reported to occur in brain and blood 
tissues. This enzyme promotes the conversion of the abnormal L-isoAsp residue into L-aspartyl, thus 
“repairing” the isopeptide bond and preventing the accumulation of conformationally altered, 
dysfunctional proteins. 
Our previous work demonstrated the antiapoptotic action of PCMT1 and proposed a mechanism of 
action, based on the ability of this methyltransferase to maintain the structural stability of some crucial 
antiapoptotic proteins, including BclxL (1). Recently we demonstrated that PCMT1 silencing induces 
increased susceptibility to apoptosis in an hepatocarcinoma cell line (2). 
Zoledronic acid (ZOL) is a potent amino-bisphosphonate used for the treatment of bone metastases 
with recently reported antitumor activity. One of the most important limits of ZOL is the 
pharmacokinetic profile. In fact, ZOL is rapidly eliminated from plasma upon intravenous 
administration, due to renal excretion and rapid uptake and accumulation within bone (about 55% of 
the administered dose) (3). In the light of these considerations, a new formulation able to change ZOL 
pharmacokinetic and pharmacodistribution, inducing a lower drug accumulation into the bone and a 
longer half-life into the blood, would be of great potential usefulness to take advantage of the ZOL 
anti-apoptotic and anti-proliferative effect in peripheral tumours. Nanotechnologies offer a very 
powerful tool to improve pharmacokinetic profile of drugs, we designed a new delivery system for 
BPs, consisting in new self-assembly PEGylated nanoparticles (NPs) based on calcium/phosphate NPs 
and cationic liposomes (4). The new self-assembling method developed in our lab assured a ZOL 
encapsulation efficiency of about 66%, about 12-fold greater than that obtained with LIPO-ZOL.  
AIM: In this work we analyzed the correlation between PCMT1 expression and activity and the 
grading of  GBM in several  cell line.  We explored the rationale for the use of PCMT1 silencing, as a 
means to increase susceptibility of GBM cells to apoptosis, combined with treatment with free ZOL 
and encapsulated ZOL. 
RESULTS: PCMT1 expression rate and subcellular distribution in various GBM cell line reflects grade 
and malignacy of originating tumor. PCMT1 silencing improves sensitivity to chemotherapic drugs 
through enhanced susceptibility to apoptosis. Particularly we found that PCMT1-silenced GBM cell 
lines showed enhanced sensitivity to the apoptosis induced by several drugs, such as doxorubicin and 
themozolomide. PCMT1-silenced GBM cell lines treated with ZOL vehicolated in nanoparticles 
showed an increased susceptibility to apoptsis which is faster and stronger than the cells treated with 
free ZOL, 
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It is well known that passive accumulation of nano-sized systems in tumor and inflamed tissue is due 
to the enhanced permeability and retention (EPR) effect. Nano-sized systems with different  size and 
shape can efficiently target tissues having aberrant microvasculature characterized by an enhanced 
blood vessels permeability. In order to accumulate the nano-sized systems in tumor tissues by passive 
targeting it is mandatory to improve their blood half-life and in vivo stability by means of a suitable 
stealth coating. However the physio-pathological state of the tumor can significantly change the 
amount and the tissue distribution of a nano-sized system. Our research project is aimed to 
characterize the EPR effect using in vivo imaging modalities over several tumor-bearing mice models. 
In particular we would like to understand how the dimensions affect extravasation, the retention time 
and the depth of permeation in the tumor. To this end we will use imaging modalities like Optical 
Imaging (OI) and Photo-Acoustic Imaging (PAI). OI that exploits invisible near-infrared (NIR) 
fluorescent light (700–900 nm) has the potential to improve cancer surgery outcomes, minimize the 
time patients are under anaesthesia and lower health-care costs largely by way of its improved contrast 
and depth of tissue penetration relative to visible light. PAI has been developed extensively over the 
last decade. Possessing many attractive characteristics such as the use of nonionizing electromagnetic 
waves, good resolution and contrast, portable instrumentation, and the ability to partially quantitate the 
signal. 
In order to consider two nano-sized systems in a quite large range of size we chose albumin and Solid 
Lipid Nanoparticles (SLNs).Albumin was chosen because is the most abundant plasma protein and it 
may be simply tagged both by a fluorescent moiety using a covalent labelling, and  by non covalent 
labelling using small fluorescent dyes having a high affinity for albumin. We also developed multi-
modal SLNs loaded with a amphipilic Gd(III) complex for Magnetic Resonance Imaging and 
Indocyanine Green (ICG) or a cyanine dye like Cy5.5 to enable OI or PAI. These nanoparticles offer 
the advantage of higher stabilities with respect to nanoemulsions or liposomes due to the presence of a 
solid core in their inner structure. The physicochemical properties of different batches of SLNs were 
investigated in term of particle size distribution, zeta-potential, DSC and fluorescent properties such as 
quantum yield and photostability. First in vitro Photo-Acustic experiments with SLNs uploaded with 
ICG, showed encouraging results, while some preliminary in vivo experiments were done with multi-
modal SLNs in tumor bearing mice characterizing the nanoparticles bio-distribution  and the tumor 
targeting properties. In conclusion, we developed two nano-sized systems to get an overview on 
passive accumulation in tumor by NIR fluorescent imaging and photoacoustic techniques. This 
knowledge could be important in the future to develop imaging tools enabling the stratification of  
patients and tumors eligible for  therapies based on macromolecular or nano-sized drugs.  
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The aim of this work is to present a one-pot synthetic process leading to poly(lactide-co-glycolide)-g-
poly(vinylpyrrolidone) (PLGA-g-PVP) copolymers consisting of high molecular weight PLGA 
carrying oligomeric PVP side chains. The title copolymers were prepared by radical polymerization of 
N-vinylpyrrolidone in the presence of 50:50 PLGA acting as polymeric chain transfer agent in the 
absence of solvents. All copolymers were characterized by 1H-NMR (400 MHz), FT-IR, SEC, 
MALDI-TOF, DSC, TGA and DLS. 
 
Scheme 1. Synthesis of poly(lactide-co-glycolide)-g-poly(vinylpyrrolidone) (PLGA-g-PVP)  
  copolymers. Multiple PVP grafts are present on a single PLGA chain. 
PLGA is a lipophilic biodegradable polymer, whereas PVP is hydrophilic, biocompatible and also bio-
eliminable for molecular weights < 40.000.1,2 Both polymers have been approved for human use by the 
U.S. Food and Drug Administration, therefore the PLGA-g-PVP copolymers are eligible for medical 
applications. The water-soluble PVP portion imparts amphiphilicity to the otherwise hydrophobic 
PLGA, thus modifying its behavior in aqueous systems. In particular, PLGA-g-PVP samples 
spontaneously formed nanoparticles when dispersed in water. These nanoparticles, besides dissolving 
hydrophobic drugs, for instance antimalarial drugs, in the inner core, show higher compatibility than 
native PLGA towards many drugs known to interact with PVP. In addition, PLGA-g-PVP samples 
were co-extruded with PLGA to give nanofibrous meshes with dramatically improved wettability 
(Figure 1). These nanofibers can be used in applications involving contact with the body fluids.  
 
Figure 1. Electrospun nanofibers of PLGA with a shell of PLGA-g-PVP copolymer 
 
1. J. M. Anderson, M. S. Shive, Advanced Drug Delivery Reviews, 2012, 64, 72. 
2. X. Liu, Y. Xu, Z. Wu, H. Chen, Macromolecular Bioscience, 2013, 13, 147 
Acknowledgments: The financial support by Cariplo Foundation (ref. 2013-0584) is gratefully 
acknowledged.  
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Biopolymer based nanocarriers have been extensively studied as delivery systems for different 
therapeutics, due to their multiple favorable properties - e.g. small size, long circulation time, reduced 
opsonization, drug stability and controlled release [1-2]. 
In this study a series of biodegradable block copolymers based on polyethylene glycol (PEG) and poly 
lactide (PLA) were synthesized by ring opening polymerization (ROP). 
Successively, biocompatible PLA nanoparticles loading Noscapine were prepared using the 
nanoprecipitation method and characterized for their size, drug entrapment efficiency and 
morphology. 
Noscapine, an alkaloid derived from opium, has been widely used as antitussive agent for many years. 
However, more recently, it was discovered that it owns a tubulin binding activity. It affects the 
dynamics of microtubules resulting in arresting the metaphase of cell cycle which eventually leads to 
apoptosis of dividing cancer cells [3]. 
Artificial neural networks (ANNs) [4] were applied to predict particle size and Noscapine entrapment 
efficiency within the formed nanoparticles using different factors - i.e. copolymer molecular weight, 
ratio of polymer to drug and the number of blocks present in the copolymer backbone. 
Using these networks it was found that the copolymer molecular weight has the greatest effect on the 
nanoparticle size distribution. On the other hand, polymer to drug ratio was found to be the most 
influential factor on drug entrapment efficiency. 
ANNs may have a great impact on the design of PEG/PLA based copolymers, and they can be used to 
customize the formulations of nanoparticles that can fit required targets. 
 
 
Figure 1. Noscapine chemical structure. 
 
 
1. J. Gong, et al., J. Control. Release, 2012, 159, 312. 
2. K. Zhang, et al., J. Control. Release, 2014, 183, 77. 
3. K. Ye, et al., Proc. Natl. Acad. Sci. USA, 1998, 95, 1601. 
4. S. Agatonovic-Kustrin, et al., J. Pharm. Biomed. Anal., 2000, 22, 717. 
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Mitochondrial delivery of drugs is a key issue for the treatment of several diseases related to oxidative 
stress, but it is hampered by the peculiar structure of the two mitochondrial membranes. An efficient 
strategy for the delivery of active compounds to mitochondria exploits liposomes composed by a 
cationic natural Bolaamphipile, DQA, produced by Plasmodium Falciparum.1 Because of the extended 
delocalization of the positive charge on the headgroups, this Bolaamphipile can easily cross the 
mitochondrial membranes guided by the negative potential of the inner membrane. Following this 
strategy, we decided to synthesize and characterize the novel Bolaamphipile 1 featuring 
triphenylphosphonium headgroups, aiming at formulating mitochondriotropic liposomes. 
The aggregation properties of 1 were investigated by conductivity measurements, Dynamic Laser 
Light Scattering (DLS), and Transmission Electron Microscopy (TEM); mixed liposomes formulated 
with 1 and a natural phospholipid, 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) or 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine (DPPC),  were characterized by DLS and the toxicity of 
some formulations was assessed on a murine skeletal muscle cell line. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1  
 
1. V. Weissing, J.Lansch, G. Erdos, H.W. Meyer, T.C. Rowe, J. Huges, Pharm. Res., 1998, 15, 334. 
Acknowledgments: CB, VM, SS are grateful for the financial support from FIRB 2012 
RBFR12BUMH. 
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Aloe emodin (AE), a natural hydroxyanthraquinone from Aloe vera leaves, is reported to have 
cytotoxic activity against various cancer cell lines (1). Interestingly, AE showed an affinity for human 
breast cancer. With the aim of developing novel anticancer drugs characterized by selective targeting 
and low toxicity for normal dividing cells, we have devoted our attention to a number of natural 
compounds that have traditionally been used to treat a variety of diseases. We have assayed only 
those natural compounds showing no toxicity to normal cells, and we evaluated their efficacy against 
cancer cells.  
Our recent study clearly demonstrated the in vitro anti-proliferative effect of AE on the breast 
adenocarcinoma cell line SKBR3. Cell viability assay (MTT test) showed that AE inhibited SKBR3 
cell proliferation in a concentration- and time-dependent manner. Moreover, cell cycle was analyzed 
by flow cytometry to elucidate the mechanism of AE-induced cell growth inhibition. Cell cycle 
modifications and alteration of its regulatory proteins are frequently associated with induction of 
apoptosis. Cancer cells were incubated with or without different AE concentrations for 24, 48 and 72 
h. To determine whether AE activated apoptosis in SKBR3 cells, morphological and biochemical 
parameters were evaluated. Höechst staining and flow cytometric analysis of annexin V-FITC-
positive cells showed that AE treatment induced apoptotic death in SKBR3 cancer cells. The 
morphological alterations were evaluated by scanning electron microscopy (SEM), (Figure 1). Studies 
are in progress to evaluate different drug delivery systems (cationic liposomes, lysozyme-shelled 
hollow nano/microbubbles and nano/microcapsules) in order to increase antitumor AE efficacy on 
breast cancer, as model of solid tumor.  
 
                                       
 
1. C. Tabolacci, A. Lentini, Life Sci. 2010 (9-10), 316 
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Chitosan has been applied to promote extracellular matrix (ECM) formation in tissue regenerative 
therapy. The superior tissue compatibility of chitosan may primarily be attributed to its structural 
similarity to glycosaminoglycan in ECM. Chitosan has been reported to be biocompatible, bio-
absorbable and particularly, is considered a good wound-healing accelerator. Dermis and scaffolds 
made from chitosan exhibit weak antigenicity, biodegradability, and superior biocompatibility 
(hemostatic and cell-binding properties) by comparison to the synthetic polymers, such as poly(lactic 
acid) (PLA), poly(glycolic acid) (PGA), and polyethylene terephthalate (PET). As a scaffold, chitosan-
based materials in the form of a sponge have been considered the most popular 3D-scaffolds for 
dermal regeneration. Recently, much attention has been given to utilize tannins (natural polyphenols) 
as adjuvants in biomedical applications, for example, a wound healing agent, bandage material, skin 
grafting template, hemostatic agent, hemodialysis membrane and drug delivery vehicle.  
We isolated chitosan from native shrimp waste streams and tannins from grape and cranberry waste 
by-products. Hybrid 3D- scaffold biomaterials were successfully obtained by mixing chitosan with 
tannins at different molar ratios. Chitosan-tannin hybrid composites were formulated as a 3D sponge-
like scaffold, applying previously developed methodologies involving solvent casting and freeze 
drying. Chitosan-tannin hybrid 3D-scaffolds were characterized according to its water uptake capacity, 
thermal behavior (DSC) and morphology (SEM). 
 
 
Figure 1. Illustrative picture of Chitosan-tannin hybrid 3D-scaffolds. A- Preparation 
of hybrid scaffolds. B- Physical appearance of hybrid scaffolds. C- Swelling behavior 
of hybrid scaffolds. D, E- SEM micrographs of chitosan alone (D) and chitosan-
tannin (E) hybrid scaffolds. 
 
Chitosan-tannin hybrid 3D-scaffolds for tissue engineering have been successfully optimized and 
characterized according to its thermal behavior, water absorption capacity, porosity and morphology. 
We are currently starting cell growth studies on the scaffolds using model epithelial cells.  
 
3. J.D. Reed, C.G. Krueger, S. Madrigal-Carballo, USPTO, 2011, US 2011/0059162 A1. 
 
Acknowledgments: Authors are deeply thankful to Prof. Jess D. Reed (University of Wisconsin-
Madison, USA) for providing the tannin fractions from grape seed extract and cranberry presscake. 
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Magnetic nanoparticles (MNPS) are important contrast agents used as theranostic tools to monitor a 
wide range of disease processes. In particular, the MNPs have shown a strong tendency to be 
internalized by phagocytic cells, such as microglia, which constitute the macrophages of the central 
nervous system (CNS). Microglia are the first line of defense against invading pathogens and are also 
involved in the recruitment of immune cells from the periphery in areas of pathology. These cells are 
ubiquitous distributed throughout the CNS and constitute about 10% of the total population of glial 
cells, with a high motility and, even under the so-called 'rest' conditions, constantly monitor the local 
microenvironment for endocytosis of nutrients and clearance of cellular debris1.  
We synthesized core shell MNPs (Fe3O4@Cu @ Au)2 coated with isolectin B4 from Griffonia 
simplicifolia as this protein binds with a large affinity the α-D-galactose residues of glycosylated 
proteins present on the cell membrane of microglia3, thus allowing a specific interaction between 
nanoparticles dispersed in the culture medium and cells. Because of this interaction, the microglia 
showed a rapid and an extensive MNP uptake under basal conditions. Experimental evidence of MNPs 
internalization has been obtained by collecting AFM, MFM*, SEM and confocal fluorescence 
microscopy images of the cells, before and after incubation with the nanoparticles activated with 
isolectina B4. 
Taking advantage of the great mobility of the microglia in physiological environment, we hypothesize 
that the internalization of MNPs may be a new approach to deliver functionalized nanoparticles within 
the tissue affected by pathology (i.e. infection, cancer).  
 
(*) MFM: magnetic force microscopy 
 
 
 
 
 
 
1. M. Szabo, K. Gulya, Neuroscience, 2013, 241, 280 
2. D. Passeri, C. Dong, M. Reggente, M. Barteri, F. A. Scaramuzzo, F. De Angelis, F. Marinelli, F. 
Antonelli, F. Rinaldi, C. Marianecci, M. Carafa, A. Sorbo, D. Sordi, I.W.C.E. Arends, M. Rossi, 
Biomatter, 2014 in press 
3. W. J. Streit, G. W. Kreutzberg, Journal of Neurocytology, 1987, 16, 249 
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Catalysis, separation and sensing extensively exploit mesoporous silica adsorption properties.  Micro- 
and nano-texturing are known to be  remarkably useful for biological applications. Frustules, coming 
from diatom biosilisification, specific and really polymorphic silica shells produced by diatoms, are 
used in photonics, molecular separation and detection and biosensing [1]. We used frustules from 
Thalassiosira weissflogii, a pelagic centric diatom from Oceans, for building a chemical model for bio-
application.  Here we report frustules-based scaffold systems obtained by chemical modification of the 
outer surface of the diatom shells with a specific anti-oxidant moiety (TEMPO radical trap) via the 
APTES-method and the resulting material was also used as biosilica “sponge” for drug 
loading/delivery of ciprofloxacin (antibiotic). We then performed cell adhesion experiments to 
compare fibroblasts and osteoblasts-like cells proliferation and adhesion attitude on nano-textured 
diatom “glass” and  decorated diatom “glass” with TEMPO-APTES moiety. 
 
Figure 1. Frustules with specific chemical 
modification (TEMPO moiety) represent a 
promising candidate for bone cell adhesion. 
 
1. W. Yang, P. J. Lopez, G. Rosengarten, Analyst, 2011, 136, 42. 
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One of the major challenges of gene therapy is the development of non viral vectors for genetic 
material, such as plasmids and small interfering nucleic acid, to obtain efficient delivery systems 
without immunogenic effect respect to viral vectors. Currently, the most promising non viral vectors 
are cationic self –assembly aggregates, such as liposomes or micelles.1,2 The molecular properties of 
complexes obtained by interaction between carriers and nucleic acids are of fundamental importance 
to obtain efficient transfection agents. 
In this contribution we describe the kinetics of oligonucleotide (siRNA3 or siDNA) complexation with 
micelles formed by two types of divalent cationic surfactants, i.e. three Gemini bis (quaternary 
ammonium) bromide with variable spacer length (12-3-12, 12-6-12, 12-12-12) and one weak 
electrolyte surfactant bearing a triazine polar head. The kinetics of complexation were studied by time 
resolved Small Angle X Ray Scattering performed at the European Synchrotron Radiation Facility 
(Grenoble, France). All systems contained a fixed amount of surfactant and different concentrations of 
oligonucleotide at charge ratios (+/-) 0.75 and 1.25. Each experiment consisted on the recording of a 
total of 80 or 60 curves, collected in three different time groups: first group each 0.15 s, second group 
each 2-3 s and third group each 40-60 s.  
SAXS intensity diagrams were analyzed to investigate the interactions leading to complex formation 
and the final structure of the aggregates. This analysis allowed us to highlight differences in the 
kinetics of complexation and in the structure of the nucleic acid/micelles complexes due to the nature 
of the nucleic acid. The complexes formed by siRNA and siDNA with the micellar aggregates of 
gemini surfactant 12-6-12 were also studied by molecular dynamics simulations to obtain an atomistic 
description of the interaction between the nucleic acid molecules and the surfactant aggregates. 
 
 
Figure1. Sketch of the main steps involved in complex formation 
 
1. J.C. Burnett, J. J. Rossi and K. Tiemann, Biotechnology Journal, 2011, 6, 1130-1146. 
2. C. Bombelli, L. Giansanti, P. Luciani, G. Mancini, Current Medicinal Chemistry, 2009, 26(2), 171-183. 
3. S. Falsini, S. Ristori, L. Ciani, E. Di Cola, C. T. Supuran, A. Arcangeli and M. In, Soft Matter, 2014,10, 
2226-2233. 
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The recent advances in nanotechnology and nanomaterials have been integrated into analytical 
chemistry for the design of large numbers of fluorescent chemical and biological probes. In particular, 
nanoparticles have some advantages because they are much brighter than the single dyes since one 
particle contains several dyes molecules and their molecular size minimizes physical perturbation of 
living cells.Our continuous interest in the field of chemical approaches to target cancer cells moved us 
to study the preparation of a novel class of squalene conjugates with paclitaxel, podophyllotoxin, 
camptothecin and epothilone A. All of them were characterized by a squalene tail that makes them 
able to self-assemble in water, and to secure the release inside the cells by a disulfide-containing 
linker.1 The need to trace the delivery of the nanoassemblies and to demonstrate the internalization of 
the drugs pushed us toward the formation of heterogeneous fluorescent nanoassemblies by mixing a 
paclitaxel-squalene conjugate and fluorescein-squalene conjugate. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.Self-assembling of fluorescent hetero-nanoparticles 
 
 
To prove the capability of nanoassemblies to enter the cell, A549 cells were incubated with 
suspensions of heterogeneous nanoparticles and we noticed that fluorescent entities accumulate in the 
perinuclear region. The following application of hetero-nanoparticles is in the combined therapy. 
Mixing a paclitaxel-squalene conjugate and a cyclopamine-squalene conjugate we were able to obtain 
again hetero-nanoparticles. The preparation of fluorescent hetero-nanoparticles containing a 
paclitaxel-squalene conjugate, a cyclopamine-squalene conjugate and tetramethylrhodamine-sqalene 
conjugate serves to demonstrate the internalization of the nanoassemblies. 
 
 
 
1 S. Borrelli, M. S. Christodoulou, I. Ficarra, A. Silvani, G. Cappelletti, D. Cartelli, G. Damia, 
F. Ricci, M. Zucchetti, F. Dosio, D. Passarella Manuscriptaccepted by Eur.J.Med.Chem 
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Epigenetic events are critical contributors to the pathogenesis of cancer, and targeting epigenetic 
mechanisms represents a novel strategy in anticancer therapy. Classic demethylating agents, such as 5-
Aza-29-deoxycytidine (Decitabine), hold the potential for reprograming somatic cancer cells 
demonstrating high therapeutic efficacy in haematological malignancies. On the other hand, epigenetic 
treatment of solid tumours often gives rise to undesired cytotoxic side effects. Appropriate delivery 
systems able to enrich Decitabine at the site of action and improve its bioavailability would reduce the 
incidence of toxicity on healthy tissues. In this work we provide preclinical evidences of a safe, 
versatile and efficient targeted epigenetic therapy to treat hormone sensitive (LNCap) and hormone 
refractory (DU145) prostate cancers. A novel Decitabine formulation, based on the use of engineered 
erythrocyte (Erythro-Magneto-Hemagglutinin Virosomes, EMHVs) drug delivery system (DDS) 
carrying this drug, has been refined. Inside the EMHVs, the drug was shielded from the environment 
and phosphorylated in its active form. The novel magnetic EMHV DDS, endowed with fusogenic 
protein, improved the stability of the carried drug and exhibited a high efficiency in confining its 
delivery at the site of action in vivo by applying an external static magnetic field (1) Here we show 
that Decitabine loaded into EMHVs induces a significant tumour mass reduction in prostate cancer 
xenograft models at a concentration, which is seven hundred times lower than the therapeutic dose, 
suggesting an improved pharmacokinetics/pharmacodynamics of drug. These results are relevant for 
and discussed in light of developing personalised autologous therapies and innovative clinical 
approach for the treatment of solid tumours. 
 
 
 
1.  Cinti C, Taranta M, Naldi I, Grimaldi S. Newly engineered magnetic erythrocytes for sustained and 
targeted delivery of anti-cancer therapeutic compounds. 
PLoS One. 2011 Feb 23;6(2):e17132.  
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Aloe-Emodin (1,8-Dihydroxy-3-(hydroxymethyl)-9,10-anthracenedione) (Figure 1), AE, is an 
anthraquinone compound extracted from Aloe leaves. This anthracene derivative is a polyphenol that 
has shown many therapeutic properties, such as antineoplastic, antibacterial, antiviral, anti-
inflammatory and scavenging activity on free radicals acting through several cellular mechanism and 
pathways1. Hence, AE, due to its properties, attracts increasing interest and could be applied in the 
treatment of many diseases. Its inclusion in liposome formulations could solve the problem of its 
scarce solubility in water and allow i) controlling its pharmacokinetics and biodistribution, ii) 
increasing its accumulation in target tissues and iii) avoiding or reducing its accumulation in healthy 
tissues, thus reducing its toxicity and side effects. The weak acid nature of AE, due to its two phenolic 
functions, could be exploited to remotely load it in the internal aqueous phase of liposomes.  
In fact weak acids can accumulate in the internal aqueous compartment of lipid vesicles in response to 
a difference in pH between the inside and the outside of the liposomes, pHin>pHout2. 
Here we report the inclusion of AE in gemini based cationic liposomes by the acetate gradient method3 
(remote loading). A number of different cationic liposome formulations composed of different ratios 
of natural phospholipids, namely DMPC (1,2-dimyristoyl-sn-glycero-3-phosphatidylcoline), DPPC 
(1,2-dipalmitoyl-sn-glycero-3-phosphocholine), DOPC (1,2-dioleoylsn-glycero-3-phosphocholine), or 
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), and one of two diastereomeric gemini 
surfactants (Figure 1), (2S,3S)-2,3-dimethoxy-1,4-bis(N-hexadecyl N,Ndimethylammonium)butane 
bromide, 1, or (2R,3S)-2,3-dimethoxy-1,4-bis(N-hexadecyl-N,Ndimethylammonium)butane bromide, 
2, and cholesterol were explored for the inclusion of AE. 
 
 
 
 
 
 
 
 
 
 
 
 
           Figure 1 
 
 
 
1. Q. Huang, M. H. Shen, C. M. Chung, N. C. Ong, Medicinal Research Reviews, 2007, 27, 609 
2. Liposome Technology, Volume II, 28 
3. S. Clerc, Y. Barenholz, Biochim. Et Biophys. Acta, 1995, 1240, 257 
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The protein-carbohydrate recognition phenomena can be used for the targeted drug delivery, 
exploiting the numerous specific carbohydrate receptors present on the cell membrane.1 Liposomes are 
well known as drug delivery systems and, in some cases, functionalized with sugar units, they indeed 
show targeting properties on the basis of these processes.2 In other examples, the functionalization of 
the lipid bilayer with bolaamphiphiles gives rise to liposomes with higher rigidity and lower 
permeability, improving their ability in entrapping molecules.3 
We recently prepared two new bolaamphiphiles characterized by the presence of active polar heads for 
targeting, based on calixarenes in the so-called 1,3-alternate geometry and functionalized with four 
units of glucose and cellobiose (glycocalix[4]arenes).4 Experiments to determine the incorporation of 
these glycocalixarenes into lipid bilayers of DOPC liposomes, permeability and entrapment properties 
of these mixed liposomes, and interaction with a glucose recognition lectin (ConA) were successfully 
performed.4 Moreover, targeted delivery experiments were performed towards human breast cancer 
cells (MDA-MB-231) over-expressing the glucose receptor GLUT1, by using DOPC and 
DOPC/calixarene mixed liposomes fluorescently labelled with a N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) 
(NBD) tagged lipid. The preliminary results collected by laser scanning confocal microscopy indicate 
that the uptake of liposomes containing the glucosylated calixarenes is significantly higher respect to 
the uptake of DOPC liposomes suggesting the occurrence of a receptor mediated process. The use of 
bola-shaped glycocalix[4]arenes could be then a novel successful strategy to functionalize liposomes 
and obtain drug delivery systems able to target specific lectins, cells and tissues. 
 
 
 
1. Gabius H.-J.,  Wiley-VCH, Weinheim, The Sugar Code. Fundamentals of glycosciences, ed. 2009 
2. Matsui M., Shimizu Y., Kodera Y., Kondo E., Ikehara Y., Nakanishi H. Cancer Sci. 2010, 101, 
1670 
3. Benvegnu T.; Réthoré G.; Brard M.; Richter W.; Plusquellec D., Chem. Commun., 2005, 44, 5536 
4. a) Sansone F.; Casnati A, Chem. Soc. Rev., 2013, 42, 4623; Aleandri S.; b) Casnati A.; Fantuzzi 
L.; Mancini G.; Rispoli G., Sansone F., Org. Biomol. Chem., 2013, 11, 4811 
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Liposomes are lipid vesicles that can be functionalized with fluorescent surfactants in order to apply 
them as sensors. We have exploited such approach trying to verify the potential of using lipid’s 
structure reorganization (for different formulations) in order to develop specific sensors. Structure 
features (like internal reorganization) can be probed by the ratio between excimer and monomer 
fluorescence, according to the fluorescent surfactant concentration. 
We investigated the excimer/monomer ratio formulated with an amphiphilic fluorescent molecule and 
phospholipid to elucidate the lipid organization. The fluorescent amphiphilic is characterized by a 
pyrrolidinium headgroup and a hydrocarbon tail tagged with a pyrene residue[1](1). We have 
investigated the influence of vesicle size and temperature on the lipid organization.  
 
 
 
 
Figure 1. Molecule of fluorescent surfactant. 
 
 
 
1. Bombelli, C. et al., New pyrenil fluorescent amphiphiles: synthesis and aggregation properties, Soft 
Matter, 2011, 7, 8525. 
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Among all the currently employed nanovectors, surfactant vesicular systems are rapidly gaining 
popularity as vectors for delivering drugs to target organs and cells [1]. 
Chitosan-coated surfactant vesicles were proposed as targeting vectors for myogenic differentiation. 
Chitosan's key properties are its biocompatibility, bioactivity, nonantigenicity and nontoxicity (its 
degradation products are known natural metabolites).  
Surfactant vesicles coated with a chitosan shell were prepared and characterized in terms of size 
(dynamic light scattering), shape (electron microscopy after freeze-fracture), zeta potential 
(electrophoretic mobility), bilayer fluidity and polarity (fluorescence studies), formulation stability 
(dynamic light scattering). Carrier stability in fetal bovine and human serum were evaluated and 
release kinetics of model molecules from selected formulations (fluorescence studies, HPLC) were 
performed. Chitosan-coated surfactant vesicles, containing a fluorescent dye, were added to C2C12 
skeletal muscle cell lines and fluorescence was measured by flow cytometric analysis. 
 
Figure 1. Flow cytometry analysis of nanoparticles cellular 
uptake in C2C12 cells.. The Q3 quadrant indicates percentage of 
calcein positive and 7 Amino-Actinomycin D (7-AAD) negative 
live cells. 
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The highly specific interactions of carbohydrates with lectins, a class of sugar-binding proteins 
without enzymatic activity, are involved in a wide variety of cellular recognition processes including 
bacterial and viral infections, immune response and tissues growth.1 Since lectins have been found to 
locate on various cell surfaces, including microbial and viral ones, targeting devices exploiting the 
recognition of sugar moieties have been frequently investigated in recent years.2 Glycosylated 
liposomes (glycoliposomes), obtained by functionalization of vesicles with glycosylated amphiphiles, 
represent a promising approach to improve the selective targeting of drugs to diseased tissues in vivo, 
leading to reduction in drug toxicity and improved therapeutic outcomes. 
Herein it is reported on the capability of the new glucosylated synthetic amphiphiles 1 and 2 to interact 
with the plant lectin Concanavalin A (Con A), used as model system, as pure components and in 
formulation with dimyristoyl-sn-glycero-phosphocholine (DMPC) at 5:95 molar ratio. Experiments on 
breast cancer line cells showed an enananched cellular uptake of the glycoliposomes with respect to 
DMPC vesicles. 
 
O
N N
N
O
N
3
15
Br
2
O
HO
OH
OH
HO
O
HO
OH
OH
HO
O
O
3 N N
N
O
N
3
15
Br
1
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In many biological processes, based on molecular recognition phenomena, carbohydrates play a 
central role. The interactions between saccharides and proteins are in fact important for different cell 
activities like proliferation or intercellular communication, but they also mediate the beginning and 
development of pathological events. These interactions are strengthened by the glycoside cluster 
effect: multiple identical binding sites simultaneously bind multiple identical saccharide units. The 
design and synthesis of molecules for the interaction with cells or microorganisms can take advantage 
by this concept of the multivalent glycoside-protein recognition in order to improve the specificity and 
efficiency of the binding. 
In this field, calixarenes, macrocycles obtained by phenol-formaldehyde oligomerization, constitute a 
perfect scaffold for the synthesis of polyglycosylated ligands.1 In fact, valency and geometry of the 
sugar units display can be easily tuned with the possibility of obtaining small libraries of potential 
biologically active compounds.  
We present here some recent works of our laboratory, in which the functionalization of calixarenes 
with specific saccharide units selected on the basis of the biological target, pointed out interesting 
results. The inhibition of two different galectines has been reached with two isomers of a 
calix[4]arene, both functionalized with four lactoside units.2 A calix[5]arene bearing five units of GM1 
tetrasaccharide has been developed for the inhibition of the cholera toxin.3 A 1,3-alternate 
glucocalixarene, able in binding Concanavalin A, was successfully introduced in a liposome bilayer.4   
 
 
Figure 1. Possible biological applications of glycocalixarenes. 
 
1. F. Sansone, A. Casnati, Chem. Soc. Rev., 2013, 42, 4623. 
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Expression of viral structural proteins, such as those of the pericapsid or capsid, may cause the self-
assembly of protein oligomers in Virus Like Particles (VLPs) or nanotubes (NTs). In recent years 
VLPs were produced in Euchariotic  cells like insect cells and mammalian cells with the complexity 
and high costs associated with such expression systems. The expression of these viral proteins in 
bacterial cells has been limited by their poor solubility and their subsequent accumulation within the 
inclusion bodies. The recent development of a new prokaryotic expression system that uses the 
fragment SUMO (Small Ubiquitin-like Modifier) as a fusion partner, opens new scenarios in the 
production of these particles. Using this system we developed and optimized a biotechnological 
platform in Escherichia coli for the expression and purification of the soluble viral VP6 protein from 
human rotavirus. We produced VLPs and NTs from VP6 at different pH values in an efficient and 
reproducible way, verified and characterized by means of TEM and AFM. Both nanoparticles 
administrated to different groups of mice showed strong immunogenicity with high levels of systemic 
IgG response  with the tubular structural conformation as the most immunogenic one. The interest in 
developing and refining new approaches to manipulate the mechanical properties of low-cost VP6 
nanoparticles is rapidly increasing, in order to improve their suitability for biomedical applications. In 
this regard, in addition to deepen the immunogenic properties of these particles, our work plans to use 
these nanoconstructs as a carrier of bioactive molecules. The increasing number of multidrug resistant 
(MDR) bacteria is rapidly becoming a global problem. Since the difficulty to obtain new effective 
antibiotics, the development of new drugs, beside antibiotics, is becoming of great relevance. In order 
to face this problem, the aim of our future work is to design, synthesize and test in vitro and in vivo, a 
new type of multivalent drug based on VP6 Virus Like Particles functionalized with Anti-Microbial 
Peptides (AMPs), normally produced by the Human Innate Immune System. 
 
 
Figure 1. Atomic force microscopy images collected 
in contact operation mode, at different pH and ionic 
strength.  
(A) Representative 2-D image of a spherical virus-
like particle detected at pH4.5.  
(B, D) 3-D representation of the same images in (A) 
and (C), respectively.  
(C) Representative 2-D image of an elongated 
wormlike nanotube detected at pH6. 
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The identification and quantification of bacteria, that affects human life both directly causing diseases 
and indirectly contaminating natural ecosystems, are mostly carried out with culture plating, enzyme-
linked immunosorbent assay (ELISA) and Polymerase Chain Reaction (PCR)1. These methods are 
quite expensive and time-consuming, as a consequence the number of analysis to be performed is 
usually kept to a minimum. Therefore, there is the need for rapid and economic methods for detecting 
bacteria in the environment and in diagnostics. 
Within the AQUALITY2 project (funded by FP7-SME-2011-1) we propose an innovative approach, 
the use of engineered liposomes for detecting bacteria in drinkable water. 
Our idea consist in preparing cationic liposomes functionalized with a proper probe, that will produce 
an optical signal (changes in the emission) due to an interaction between liposomes and bacteria. We 
have prepared and characterized a large number of liposomes formulated with a natural phospholipid 
and a synthetic cationic component. In particular, we have evaluated their dimension, their capability 
of retaining the probe and their Zeta potential in the presence and in the absence of bacteria (Figure 1) 
in order to select the formulations most suitable for the interaction. Finally, the most promising 
formulations were tested against specific bacterial strains (Staphylococcus aureus, Escherichia coli, 
Enterococcus faecalis) and the change in the fluorescence emission of the entrapped probe was 
evaluated as a function of bacterial concentration. One of the tested formulations is able to detect up to 
102 CFU/mL of bacteria. 
These encouraging results could also be exploited for the formulations of liposome for the 
identification of bacteria in biological fluids.  
 
 
 
1. Diamond D., Analytical Chemistry,2004, 76, 278A 
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Graphene, a single, tightly packed layer of carbon atoms bonded together in a hexagonal honeycomb 
lattice, is stimulating research on related structures, such as Graphite NanoPlatelets (GNPs), a 1-15 nm 
thick flake, constituted of 3-48 layers of graphene, because of their unique structures, properties and 
possible applications. Graphene and its derivatives have shown outstanding potentials in many fields, 
such as nanoelectronics, composite materials, energy technology, sensors, and catalysis. Beyond the 
applications aforementioned, the biomedical application of graphene is a relative new area with 
significant potential1. Due to the expanding applications of nanotechnology, human and environmental 
exposures to graphene-based nanomaterials are likely to increase in the future. However, the 
prospective use of graphene-based materials in a biological context requires a detailed comprehension 
of their toxicity.  
Herein, we report on the interaction of stable and evenly dispersed exfoliated GNPs obtained using an 
ultrasonic bath for different times (30, 50 and 70 min) with human breast adenocarcinoma cells 
(SKBR3 and MDA-MB-231) for 24-48-72 hrs. Biocompatibility of nanoplatelets has been evaluated 
by MTT while cell viability has been detected using Trypan Blue assays. Our results showed that 
GNPs particles were more cytotoxic in SKBR3 than MDA-MB-231 cells suggesting a cell phenotype-
dependent effect. 
Furthermore, light microscopy observations and scanning electron microscopy analysis were used to 
gain understand on the mechanism of cell-nanoplatelets interaction. 
Our studies carried out with interdisciplinary approaches among chemistry, biology and engineering, 
can contribute to the mechanistic understanding of graphene-based platforms for bio- and 
nanomedicine applications. 
 
 
 
 
 
1. H. Shen, L. Zhang, M. Liu, Z. Zhang, Theranostics, 2012, 2(3), 283. 
 
Figure 1. SEM micrograph of cancer cell-GNPs interactions 
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Among all the currently employed nanovectors, surfactant vesicular systems are rapidly gaining 
popularity as vectors for delivering drugs to target organs and cells [1]. 
Chitosan-coated surfactant vesicles were proposed as targeting vectors for myogenic differentiation. 
Chitosan's key properties are its biocompatibility, bioactivity, nonantigenicity and nontoxicity (its 
degradation products are known natural metabolites).  
Surfactant vesicles coated with a chitosan shell were prepared and characterized in terms of size 
(dynamic light scattering), shape (electron microscopy after freeze-fracture), zeta potential 
(electrophoretic mobility), bilayer fluidity and polarity (fluorescence studies), formulation stability 
(dynamic light scattering). Carrier stability in fetal bovine and human serum were evaluated and 
release kinetics of model molecules from selected formulations (fluorescence studies, HPLC) were 
performed. Chitosan-coated surfactant vesicles, containing a fluorescent dye, were added to C2C12 
skeletal muscle cell lines and fluorescence was measured by flow cytometric analysis. 
           
Figure 1. Flow cytometry analysis of nanoparticles 
cellular uptake in C2C12 cells.. The Q3 quadrant 
indicates percentage of calcein positive and 7 Amino-
Actinomycin D (7-AAD) negative live cells. 
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In the field of nanomedicine, the characterization of functionalized drug delivery system,  represents a 
pivotal aspect of great importance. In this study, PLGA nanoparticles functionalized with three 
different kinds of ligands (carbohydrate ligand, antibody and quantum dots crystals) were intentionally 
designed, created and tailored with specific physico-chemical properties to meet the needs of specific 
applications (cell targeting or imaging). We applied and combined two advanced microscopies as 
AFM and TEM, optimizing the preparative procedure to discriminate amongst the ligands conjugated 
on the NP surface. Despite the high resolution of the two microscopical techniques, low molecular 
weight molecules, such as sugar residues (Neu5Ac), anchored to the surface of polymeric NP were not 
detectable. On the contrary, due to the different nature of the ligands with respect to the polymer 
(PLGA) of the NPs,  the CdSe/CdZnS core of the PEG-QD anchored on NPs surface was clearly 
detected by using TEM. TEM analysis of complex and high molecular weight molecules, such as 
antibodies conjugated to the surface of NPs, required a preliminary procedure with gold particles 
staining and labeling of the samples. In contrast, the AFM allowed to discriminate on the qualitative 
evaluation of both QD and antibody, without any additional treatment of the samples and without 
operating in a vacuum environment. Moreover, AFM images shows 3D-data allowing the height of the 
observed object to be measured. Also the heterogeneity/discontinuity of the coverage or the surface 
alteration obtained during the functionalization of NPs can be defined. Hence, AFM can support 
additional analytical techniques allowing a detailed sample characterization.  
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Figure1: TEM and AFM images 
of  antibody (Ab) conjugated 
nanoparticles (NPs)
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Combinations of different nanostructured materials are considered promising tools to allow the 
development of multifunctional nanomedicines for multimodal imaging [1]. QDs and polymeric 
nanotechnology revealed to be a good binomial for these applications. In fact, the sensitive and fast 
responsive fluorescent imaging method using QDs as probes can dynamically monitor the behavior of 
labeled nanocarriers in both cells and animals. Moreover, fluorescence quenching of quantum dots is 
one of the most interesting and useful photochemical phenomena [2, 3], but still poorly investigated. 
The comprehension of polymer interaction with the metallic QD surface must be absolutely 
considered to finally display of a detailed chemico-physical and biological characterization of these 
systems.  
In this study, we compared two different synthetic procedures to obtain QD-labeled polymeric 
nanoparticles (NPs), investigating if the optical properties of QDs (i.e. the intensity of fluorescence) 
may change accordingly to the formulation methods, as a consequence of the different polymeric 
environment.  
By AFM and TEM characterization and by confocal experiments, we demonstrated that NPs modified 
with QDs after the formulation process (post-NPs-QDs) conserved the photophysical features of QD 
probe. On the contrary, by using a polymer modified with QDs to formulate NPs (pre-NPs-QDs), a 
significant quenching of QD fluorescence and a blue-shift in its emission spectra were observed.  
Our results suggest that fluorescence quenching phenomenon appears to be due to the packaging of 
QDs into the polymeric matrix. The dissolution of the polymeric matrix in DMSO reverted the 
quenching phenomenon, allowing a recovery of the fluorescence and, in part, no-shifted emission 
peak.  
These results can be exploited to develop nanosystems for imaging and biological applications as NPs 
labeled with QDs, if safe and characterized in depth, can represent useful tools for treatment, diagnosis 
and monitoring of biological systems at the level of single molecule or molecule assemblies.  
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2. Y. Wang, L. Chen, Nanomedicine: NBM, 2011, 7, 385. 
3. L. Shen, J. Funct. Biomater, 2011, 2, 355. 
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Alterations in the homeostasis of brain cholesterol (Chol) have been described in neurodegenerative 
diseases such as Huntington's disease (HD). Reduction of brain cholesterol (Chol) biosynthesis and 
level has been described in Huntington’s disease (HD) [1], a neurodegenerative genetic disorder that 
leads to motor defects and cognitive decline. The implementation of Chol in brain, through delivery of 
exogenous Chol, has thus been reported could be a feasible approach to HD. Unfortunately, Chol does 
not cross the blood-brain barrier (BBB) in suitable amounts after systemic administration. Several in 
vivo and in vitro studies demonstrated that NPs based on FDA approved poly(D,L-lactide-co-
glycolide) when functionalized with a glycopeptide (g7-NPs) are able to cross the BBB delivering 
drugs into the brain [2-4]. Starting from these premises, we aimed to obtain g7-NPs able to release 
Chol in brain after having optimized the technological conditions and parameters of their preparation. 
We investigated both the physical and technological parameters (the mean nanoparticle size, the 
morphology, the architecture and the surface properties) of the g7-NPs loaded with Chol, 
demonstrating the stability of drug embedded into the matricial structure. The Chol release was 
evaluated by means of in vitro studies analyzing its concentration in buffer at a pH 7.4 (under perfect 
sink conditions) by a gas chromatography (GC)/mass spectroscopy (MS) method. The release of Chol 
was characterized by an initial “burst effect” attributed to the fraction of Chol adsorbed or close in 
contact with the surface of the NPs, and by a second phase, from day 5 and day 10, with slow linear 
release of Chol ascribable to the NPs degradation. Also the uptake of NPs by brain cell cultures 
expressing mutant huntingtin (NS-hdhQ140/7) and the Chol release in these cells, were evaluated by 
loading the fluorescent NBD-Chol probe, confirming the slow kinetic profile of drug release from 
nanoparticles. Finally, in vivo experiments were carried out. g7-NPs loaded NBD-Chol were intra-
peritoneal (i.p.) administered in a transgenic mouse model of HD ( R6/2) [5] to monitor the uptake, 
the qualitative biodistribution and the release of drug in animal brains. Few hours after administration, 
g7-NPs were localized in several cerebral areas. Confocal studies demonstrated that within 14 days, 
degradation of particles started and the release of Chol occurred. 
 
 
 
1. M. Valenza, E. Cattaneo, Trends Neurosci., 2011, 34, 474. 
2. L. Costantino, F. Gandolfi, G. Tosi, F. Rivasi, M.A. Vandelli, F. Forni, J. Control. Release, 2005, 
108, 84.  
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Chem., 2013, 20, 2212.  
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Recently experimental evidences demonstrated that BLIMP-1 is a possible target for down-regulation 
by micro RNA in diffuse large B-cell lymphomas of the activated B-cell type as Primary Effusion 
Lymphoma (PEL),  a B cell non-Hodgkin lymphoma involving the serous cavities invariably 
associated with Human HerpesVirus-8 (HHV8) characterized by poor prognosis [1, 2]. However, in 
vivo systemic delivery of micro RNA or siRNA-based therapeutics to tumour cells remains a 
challenge. The major limitations against the use of siRNA as a therapeutic tool are its degradation by 
serum nucleases, poor cellular uptake and rapid renal clearance following systemic administration. In 
this contest we proposed a pegylated cationic lipoplexes to administer therapeutic siRNA in PEL 
therapy. Near the physicochemical properties (size, zeta potential, morphology  and  structure), siRNA 
loading and the efficacy to mediate gene silencing in PEL cells were evaluated. The post  pegylation 
via DSPE-PEG micelles of preformed lipoplexes produced the organized and stable structures that 
maintained siRNAs protect exerting both an efficient transfection and release of active fragment into 
PEL cells with an high gene silencing.  
 
Figure1: AFM and TEM images of lipoplexes and PEG lipoplexes. 
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Self-assembling peptide-based nanotubes are widely investigated for the development of novel 
biomaterials.1 Among the strategies developed for peptide nanotube engineering, those characterized 
by regularly alternating enantiomeric sequences are particularly attractive. In fact, they self-assemble 
in stacks directed and stabilized by hydrogen bonds forming hollow tubular architectures where the 
side chains are located on the periphery, as a consequence of the residue configuration. 
The preparation and structural organization of a new bioinspired nanomaterial are described. The 
hybrid conjugate, Cbz-(L-Ala-D-Val)4-NH-(CH2-CH2-O)45-CH3 (PEP8-PEG) (Figure 1A) was obtained 
end-linking the linear peptide with regularly alternating configurational sequence, Cbz-(L-Ala-D-Val)4-
OH, synthesized via solid-phase peptide synthesis, to a poly(ethylene glycol) (PEG) chain derivatized 
as amine. NMR, CD and fluorescence measurements and DLS and TEM results show that this 
conjugate is able to self-assemble in water forming well-defined nanorods having core/shell 
morphology with an internal peptide single channel (Figure 1B) that has been clearly visualized by 
TEM images (Figure 1C). The synthetic strategy and the structure of the conjugate ensure a controlled 
and regular pegylation of the aggregates and high density PEG blocks in the corona making 
the nanoparticles more resistant to phagocytosis and able to prevent biofouling. Such features along 
with biocompatibility and stability make these nanoparticles highly promising candidates for drug 
delivery. 
 
 
 
Figure 1. A) Molecular formula of the pegylated L,D-peptide: B) structural model of the 
nanoparticle obtained for self-assembling of PEP8-PEG; C) a selected TEM image of the 
self-assembled PEP8-PEG. 
 
 
1. I. W. Hamley, Biomacromolecules, 2014, 15, 1543. 
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There is a great deal of interest in regenerative medicine due to its capability to generate powerful new 
treatments for a wide range of diseases and injuries. 
In this context, self-assembling peptides (SAPs) are an appealing class of materials due to their ability 
to organize in nanostructured hydrogels that can be successfully anchored to appropriate substrates 
(such as for example the biocompatible TiO2 [1]), or directly injected into a lesion. SAPs scaffolds are 
able to mimic the structure of the extra-cellular matrix (ECM), offering tridimensional support for cell 
growth and/or becoming vehicles for the delivery of stem cells or drugs [2]. Indeed nanomaterials, 
eventually combined with growth factors, may constitute a biomimetic matrix with the ability of 
surrounding cells and promoting specific interactions with them, in order to control and conduct their 
behavior by mimicking their native environment. The ideal matrix must have a 3D geometry similar to 
the extracellular matrix and must be able to promote cell adhesion, proliferation, infiltration and 
differentiation aimed at new tissue formation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Scheme of self-assembling peptide (EAK16-II) 
 
 
The realization of self-assembling peptides should include a first step of chemical and structural 
characterization, to check the stability of the molecular structure following the scaffold’s development. 
In this work, we present an accurate spectroscopic investigation of different classes of hydrogel 
materials using X-ray photoelectron spectroscopy (XPS) and Fourier-Transform Infrared spectroscopy 
(FT-IR) techniques. XPS and FT-IR are successfully used to probe the chemical composition, 
molecular structure and conformation of the proposed materials. Specifically we focus on verifying the 
stability of the antiparallel β−sheet structure after self-assembling.  
 
 
[1] Dettin M., Zamuner A., Iucci G., Messina G.M.L., Battocchio C., Picariello G., Gallina G., 
Marletta G., Castagliuolo I., Brun P. Journal of Peptides Science 2014 in press 
[2] Flamia R., Salvi A.M., D'Alessio L., Castle J.E., Tamburro A.M. Biomacromolecules 2007, 8, 
128-38. 
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Recently, in a pilot study [1] has been demonstrated the feasibility of a smart controlled delivery from 
magnetic vesicles through an alternating magnetic field (AMF) with intensity significantly lower than 
the usual ones reported in literature unable to generate heat. Therefore, the drug release from the 
magnetically responsive vesicles (MLs) is controlled by mechanical oscillations induced alone on the 
magnetic nanoparticles by the AMF action. This could represent a clear advantage for therapeutic 
applications: the tissues are not affected neither by the temperature elevations nor by the eddy currents 
induced by the field, thus preventing damage and safety secondary effects [2]. Based on these 
encouraging results, to establish whether a non-thermal magnetic field could be effectively used to 
remotely control the release of an entrapped cargo from phospholipid vehicles, commercially available 
magnetic carboxymethyl-dextran coated Fe3O4 nanoparticles (MnPs) have been embedded in the 
aqueous core of saturated soybean phosphatidylcholine (HSPC)/cholesterol liposomes which exhibit 
high in vitro stability with respect to temperature (Tm higher than physiologically acceptable 
temperature), fig. 1A. Samples were exposed for different time intervals at 37.0±0.5°C to a low 
amplitude AMF (20 kHz, H field 60 A/m), and the release of the co-entrapped hydrophilic model 
drug, 5(6)-carboxyfluorescein (6-CF), was compared to the one obtained in isothermal conditions in 
the absence of the magnetic field application (sham situation), fig. 1B. Results provide evidence of 
AMF mechanical destabilization effects.  
        
Figure 1. A. Release amount of 6-CF from MLs after 3h of heating (dashed line) and differential 
scanning calorimetric profile (solid line) of HSPC/cholesterol/MnPs mixture as a function of 
temperature. B. Experimental comparison of the release of the 6-CF loaded MLs both for AMF 
exposure and for the sham condition, at increasing exposure times. Release profile of control 
liposomes (without MnPs) is also reported.  
 
 
[1] R. Spera, S. Petralito, M. Liberti, C. Merla, G. D’Inzeo, R. Pinto and F.Apollonio, 
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The ultrasound-assisted self-assembly and cross-linking of lysozyme at the water–air and water–
perfluorohexane interfaces are shown to produce lysozyme-shelled hollow microbubbles (LSMBs) 
and microcapsules (LSMC), respectively. The interaction of LSMBs and LSMCs with human breast 
adenocarcinoma cells (SKBR3) is studied (1). The cellular internalization kinetics of LSMBs and 
LSMCs and the effects on cell cycle are evaluated using flow cytometry. Evidence for the 
internalization of microparticles and degradation within the cell are also monitored by confocal and 
scanning electron microscopic analyses. The integrity of cell membrane and cell cycle are not 
affected by LSMBs and LSMCs uptake. These studies show that the positively charged LSMB and 
LSMC are not cytotoxic and can be readily internalized and degraded by the SKBR3 cells. LSMBs 
and LSMCs show a different uptake kinetics and intracellular degradation pattern due to differences 
in the arrangement of the protein at the air–liquid or oil–liquid interfaces (Figure 1). 
 
Figure 1. After cell treatment for 60 min with LSMBs (a) and LSMCs (b) SEM observations 
reveal the strong adhesion of MCs on cell surface with the formation of ruffles (arrows) without 
inducing cytotoxic effects. 
 
 
 
1. F. Cavalieri, M. Colone, Particles and Particles Systems Characterization, 2013, 1 
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Nanostructured materials are particularly interesting due to their high surface area-volume ratio and 
synergetic effects, which are useful for medicine, optics, and sensing applications.[1-4] In particular 
gold and silver nanoparticles (AuNPs, AgNPs) are promising materials in nanomedicine applications. 
In this work we present recently results obtained for the development of water-soluble gold and silver 
nanoparticles stabilized with hydrophilic ligands: a dye is bonded on particles, as schematically shown 
in figure 1, in order to obtain dye doped metal nanosystems, in analogy to polymeric systems, 
exploitable in biomedical applications.[5,6]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Reaction scheme to obtain dye doped AuNPs.  
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The research for new fluorescent materials recently became even more urgent because of the advent of 
new imaging techniques that gave a strong impulse to the development of “smart” nano-systems such 
as environment sensitive (fluorogenic) and photo-activable nano-probes. Aggregation induced 
emission (AIE) is surely an attractive mechanism for designing “smart” responsive probes.1 
Nevertheless this process is peculiar of a limited range of dyes while most fluorophores undergo 
aggregation caused quenching (ACQ). Here we demonstrate that the use of nano-aggregates, non-
fluorescent because of ACQ, can become a very general strategy for the design of new fluorogenic 
nano-probes exploiting a process specular to AIE namely disaggregation induced emission (DIE). In 
particular we will describe the efficient microwave assisted synthesis of a new strongly fluorescent 
perylene derivative that can be dispersed in water in the form of self-assembled non fluorescent NPs.2 
We will demonstrate that these NPs are efficient fluorogenic imaging agents in the case of model cells 
and that controlling the dosage either green or red fluorescence can be obtained. The same NPs can be 
used to achieve multi-colour fluorescence imaging by photo-activation of the sample. Thanks to these 
features, to the lack of toxicity and to the versatility of the proposed synthetic methodology we believe 
that our approach can inspire the design of new smart imaging agents for application in life sciences. 
 
 
Figure 1. The perylene derivative P aggregates in PBS and forms NPs quenched by ACQ. Uptake by cells 
leads to disaggregation of the NPs and to fluorescence recovery (DIE). The cells become green fluorescent 
(A) or redfluorescent (B) respectively at low and high NPs dosage. Exposition to strong visible livisible 
light allows the photo-tuning of the emission (PTE) of specific cellular compartments (C). 
 
 
 
[1] Y. Hong, J. W. Y. Lam and B. Z. Tang, Chem. Soc. Rev., 2011, 40, 5361-5388. 
[2] M. Montalti, G. Battistelli, A. Cantelli and D. Genovese, Chem. Commun., 2014, 50, 5326-5329. 
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